Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-186-5p APC 0.45 0.18545 -0.08 0.84234 miRNAWalker2 validate -0.19 0.00487 NA
2 hsa-miR-30a-3p APC -1.22 0.16757 -0.08 0.84234 MirTarget; miRNATAP -0.11 1.0E-5 NA
3 hsa-miR-320b APC 0.2 0.72722 -0.08 0.84234 miRanda -0.12 0.00135 NA
4 hsa-miR-374b-5p APC -0.11 0.76489 -0.08 0.84234 mirMAP -0.19 0.00128 NA
5 hsa-miR-590-3p APC 2.35 0 -0.08 0.84234 PITA; miRanda; mirMAP; miRNATAP -0.17 0.0001 NA
6 hsa-miR-7-1-3p APC 1.43 0.00471 -0.08 0.84234 MirTarget -0.15 0.00061 NA
7 hsa-miR-125a-5p APC2 -1.32 0.00714 3.13 0.00737 mirMAP -0.85 0 NA
8 hsa-miR-194-3p APC2 1.92 0.10538 3.13 0.00737 mirMAP -0.16 0.00507 NA
9 hsa-miR-28-5p APC2 -0.82 0.02212 3.13 0.00737 mirMAP -0.67 0.00043 NA
10 hsa-let-7a-3p AXIN2 0.83 0.04681 -3.82 0.00033 miRNATAP -0.49 0.00085 NA
11 hsa-let-7b-3p AXIN2 0.59 0.20051 -3.82 0.00033 miRNATAP -0.5 0.00019 NA
12 hsa-let-7f-2-3p AXIN2 1.03 0.07873 -3.82 0.00033 MirTarget -0.36 0.00084 NA
13 hsa-miR-15a-5p AXIN2 2.05 0 -3.82 0.00033 MirTarget; miRNATAP -0.55 8.0E-5 26252081 The combination of miR-15a and AXIN2 significantly improved the diagnostic accuracy
14 hsa-miR-15b-5p AXIN2 3.32 0 -3.82 0.00033 miRTarBase; MirTarget; miRNATAP -0.47 0.00022 NA
15 hsa-miR-16-2-3p AXIN2 3.8 0 -3.82 0.00033 mirMAP -0.68 0 NA
16 hsa-miR-16-5p AXIN2 2.94 0 -3.82 0.00033 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.7 0 NA
17 hsa-miR-205-5p AXIN2 8.08 0 -3.82 0.00033 miRNATAP -0.3 0 NA
18 hsa-miR-221-3p AXIN2 0.94 0.17475 -3.82 0.00033 miRNATAP -0.52 0 NA
19 hsa-miR-222-3p AXIN2 1.55 0.0223 -3.82 0.00033 miRNATAP -0.53 0 NA
20 hsa-miR-3614-5p AXIN2 4.5 0 -3.82 0.00033 MirTarget; miRNATAP -0.26 0.00012 NA
21 hsa-miR-590-3p AXIN2 2.35 0 -3.82 0.00033 MirTarget; PITA; miRanda; miRNATAP -0.5 3.0E-5 NA
22 hsa-miR-944 AXIN2 7.21 0.00082 -3.82 0.00033 MirTarget; PITA; miRNATAP -0.28 0 NA
23 hsa-let-7e-5p BTRC -0.11 0.81474 -0.39 0.22952 miRNAWalker2 validate -0.16 4.0E-5 NA
24 hsa-miR-125a-3p BTRC -0.07 0.92074 -0.39 0.22952 miRanda -0.11 0 NA
25 hsa-miR-15b-5p BTRC 3.32 0 -0.39 0.22952 MirTarget; miRNATAP -0.14 0.00015 NA
26 hsa-miR-16-5p BTRC 2.94 0 -0.39 0.22952 miRNAWalker2 validate; MirTarget; miRNATAP -0.13 0.00072 NA
27 hsa-miR-28-5p BTRC -0.82 0.02212 -0.39 0.22952 miRanda -0.24 0 NA
28 hsa-miR-339-5p BTRC 1.23 0.03075 -0.39 0.22952 MirTarget; miRanda -0.11 0.00101 NA
29 hsa-miR-3913-5p BTRC 0.15 0.73484 -0.39 0.22952 mirMAP -0.16 0.00018 NA
30 hsa-miR-505-3p BTRC 0.59 0.22694 -0.39 0.22952 MirTarget -0.1 0.00592 NA
31 hsa-miR-10a-5p CAMK2A -0.48 0.59461 -4.61 0.0001 mirMAP -0.42 0 NA
32 hsa-miR-130b-5p CAMK2A 3.74 0 -4.61 0.0001 mirMAP -0.55 0 NA
33 hsa-miR-148b-5p CAMK2A 2.81 0 -4.61 0.0001 mirMAP -0.36 0.00552 NA
34 hsa-miR-15b-3p CAMK2A 3.58 0 -4.61 0.0001 mirMAP -0.37 0.0021 NA
35 hsa-miR-19b-1-5p CAMK2A 1.51 0.00147 -4.61 0.0001 mirMAP -0.38 0.00728 NA
36 hsa-miR-25-3p CAMK2A 1.13 0.00311 -4.61 0.0001 MirTarget -0.82 0 NA
37 hsa-miR-30a-5p CAMK2A -0.77 0.32049 -4.61 0.0001 mirMAP -0.26 0.00345 NA
38 hsa-miR-30d-5p CAMK2A 0.3 0.38019 -4.61 0.0001 mirMAP -0.78 0.0001 NA
39 hsa-miR-30e-5p CAMK2A 0.78 0.03467 -4.61 0.0001 mirMAP -0.49 0.00851 NA
40 hsa-miR-32-5p CAMK2A 2.93 0 -4.61 0.0001 MirTarget -0.38 0.00666 NA
41 hsa-miR-338-3p CAMK2A 0.45 0.55849 -4.61 0.0001 miRNATAP -0.27 0.00277 NA
42 hsa-miR-361-3p CAMK2A 0.81 0.04185 -4.61 0.0001 mirMAP -0.68 8.0E-5 NA
43 hsa-miR-363-3p CAMK2A 4.27 1.0E-5 -4.61 0.0001 MirTarget -0.42 0 NA
44 hsa-miR-3913-5p CAMK2A 0.15 0.73484 -4.61 0.0001 mirMAP -0.46 0.004 NA
45 hsa-miR-429 CAMK2A 6.4 0 -4.61 0.0001 miRNATAP -0.6 0 NA
46 hsa-miR-616-5p CAMK2A 2.48 0.00318 -4.61 0.0001 mirMAP -0.44 1.0E-5 NA
47 hsa-miR-625-5p CAMK2A 2.03 0.00094 -4.61 0.0001 mirMAP -0.46 3.0E-5 NA
48 hsa-miR-7-1-3p CAMK2A 1.43 0.00471 -4.61 0.0001 MirTarget -0.37 0.00584 NA
49 hsa-miR-92a-3p CAMK2A 1.88 1.0E-5 -4.61 0.0001 MirTarget -0.41 0.00918 NA
50 hsa-miR-92b-3p CAMK2A 1.69 0.01035 -4.61 0.0001 MirTarget -0.46 1.0E-5 NA
51 hsa-miR-29a-3p CAMK2B -0.64 0.25192 1.67 0.24793 mirMAP -0.46 0.00193 NA
52 hsa-miR-29b-3p CAMK2B 0.67 0.23406 1.67 0.24793 mirMAP -0.45 0.00212 NA
53 hsa-miR-139-5p CAMK2D -2.09 0.00038 -0.44 0.41573 PITA; miRanda -0.17 0.00085 NA
54 hsa-miR-197-3p CAMK2D 1.24 0.00733 -0.44 0.41573 miRNATAP -0.2 0.00262 NA
55 hsa-miR-217 CAMK2D -0.38 0.71741 -0.44 0.41573 miRanda -0.1 0.00041 NA
56 hsa-miR-27a-3p CAMK2D 1.76 0.00022 -0.44 0.41573 miRNATAP -0.18 0.00395 NA
57 hsa-miR-30a-5p CAMK2D -0.77 0.32049 -0.44 0.41573 miRNATAP -0.11 0.00545 NA
58 hsa-miR-30b-5p CAMK2D 0.02 0.95322 -0.44 0.41573 miRNATAP -0.21 0.00569 NA
59 hsa-miR-30c-5p CAMK2D 0.39 0.34861 -0.44 0.41573 miRNATAP -0.21 0.0044 NA
60 hsa-miR-32-3p CAMK2D 2.2 0.03928 -0.44 0.41573 mirMAP -0.2 4.0E-5 NA
61 hsa-miR-320b CAMK2D 0.2 0.72722 -0.44 0.41573 miRanda -0.14 0.00911 NA
62 hsa-miR-484 CAMK2D 1.79 0.00022 -0.44 0.41573 miRNAWalker2 validate -0.19 0.00289 NA
63 hsa-miR-582-5p CAMK2D 0.69 0.44776 -0.44 0.41573 mirMAP -0.22 0 NA
64 hsa-miR-107 CAMK2G 1.49 0.00013 -0.7 0.02836 miRNATAP -0.12 0.00895 NA
65 hsa-miR-181a-5p CAMK2G 1.26 0.00749 -0.7 0.02836 miRNATAP -0.18 0 NA
66 hsa-miR-181b-5p CAMK2G 1.11 0.02734 -0.7 0.02836 miRNATAP -0.18 0 NA
67 hsa-miR-181c-5p CAMK2G -0.3 0.53753 -0.7 0.02836 miRNATAP -0.13 0.00026 NA
68 hsa-miR-484 CAMK2G 1.79 0.00022 -0.7 0.02836 mirMAP -0.11 0.00362 NA
69 hsa-miR-628-5p CAMK2G 1.05 0.02524 -0.7 0.02836 MirTarget; PITA; miRNATAP -0.17 1.0E-5 NA
70 hsa-let-7a-5p CCND1 0.15 0.64531 0.15 0.87753 TargetScan; miRNATAP -0.54 0.00245 NA
71 hsa-miR-106a-5p CCND1 3.99 0 0.15 0.87753 MirTarget; miRNATAP -0.43 0 NA
72 hsa-miR-15a-5p CCND1 2.05 0 0.15 0.87753 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.35 0.00776 22922827 CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR
73 hsa-miR-15b-5p CCND1 3.32 0 0.15 0.87753 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.42 0.00029 NA
74 hsa-miR-20b-5p CCND1 4.57 5.0E-5 0.15 0.87753 MirTarget; miRNATAP -0.31 0 NA
75 hsa-miR-34a-5p CCND1 0.83 0.04775 0.15 0.87753 miRNAWalker2 validate; miRTarBase; miRNATAP -0.42 0.00174 25792709; 21399894 This inhibition of proliferation was associated with a decrease in cyclin D1 levels orchestrated principally by HNF-4α a target of miR-34a considered to act as a tumour suppressor in the liver;Quantitative PCR and western analysis confirmed decreased expression of two genes BCL-2 and CCND1 in docetaxel-resistant cells which are both targeted by miR-34a
76 hsa-miR-497-5p CCND1 -1.44 0.02251 0.15 0.87753 MirTarget; miRNATAP -0.25 0.00498 21350001 Raf-1 and Ccnd1 were identified as novel direct targets of miR-195 and miR-497 miR-195/497 expression levels in clinical specimens were found to be correlated inversely with malignancy of breast cancer
77 hsa-miR-106a-5p CCND2 3.99 0 -2.81 0.0014 miRNATAP -0.44 0 NA
78 hsa-miR-106b-5p CCND2 2.81 0 -2.81 0.0014 miRNAWalker2 validate; miRTarBase; miRNATAP -0.31 0.00374 NA
79 hsa-miR-10a-3p CCND2 0.97 0.31667 -2.81 0.0014 mirMAP -0.2 0.00011 NA
80 hsa-miR-130b-5p CCND2 3.74 0 -2.81 0.0014 mirMAP -0.46 0 NA
81 hsa-miR-141-3p CCND2 7.3 0 -2.81 0.0014 MirTarget; TargetScan -0.24 0.00021 NA
82 hsa-miR-15b-5p CCND2 3.32 0 -2.81 0.0014 miRNATAP -0.53 0 NA
83 hsa-miR-16-2-3p CCND2 3.8 0 -2.81 0.0014 mirMAP -0.29 0.00207 NA
84 hsa-miR-182-5p CCND2 5.87 0 -2.81 0.0014 miRNAWalker2 validate; miRTarBase; miRNATAP -0.28 2.0E-5 NA
85 hsa-miR-183-5p CCND2 6.62 0 -2.81 0.0014 miRNATAP -0.29 0 NA
86 hsa-miR-191-5p CCND2 1.59 0.00074 -2.81 0.0014 MirTarget -0.32 0.00314 NA
87 hsa-miR-200a-3p CCND2 6.34 0 -2.81 0.0014 MirTarget -0.41 0 NA
88 hsa-miR-20b-5p CCND2 4.57 5.0E-5 -2.81 0.0014 miRNATAP -0.3 0 NA
89 hsa-miR-224-3p CCND2 2.85 0.00018 -2.81 0.0014 mirMAP -0.22 0.00101 NA
90 hsa-miR-28-5p CCND2 -0.82 0.02212 -2.81 0.0014 miRanda -0.43 0.00273 NA
91 hsa-miR-3065-3p CCND2 1.89 0.03082 -2.81 0.0014 MirTarget; miRNATAP -0.21 0.00027 NA
92 hsa-miR-3065-5p CCND2 2.14 0.06094 -2.81 0.0014 mirMAP -0.2 0.00026 NA
93 hsa-miR-30d-3p CCND2 -0.07 0.85742 -2.81 0.0014 mirMAP -0.55 1.0E-5 NA
94 hsa-miR-324-3p CCND2 1.51 0.00384 -2.81 0.0014 miRNAWalker2 validate -0.44 0 NA
95 hsa-miR-33a-3p CCND2 2.06 0.00156 -2.81 0.0014 MirTarget -0.27 0.00041 NA
96 hsa-miR-378a-3p CCND2 1.47 0.04667 -2.81 0.0014 miRNAWalker2 validate -0.19 0.00601 NA
97 hsa-miR-429 CCND2 6.4 0 -2.81 0.0014 miRNATAP -0.46 0 NA
98 hsa-miR-497-5p CCND2 -1.44 0.02251 -2.81 0.0014 MirTarget; miRNATAP -0.27 0.00058 NA
99 hsa-miR-550a-5p CCND2 1.22 0.06138 -2.81 0.0014 MirTarget -0.22 0.00363 NA
100 hsa-miR-660-5p CCND2 -0.07 0.88525 -2.81 0.0014 mirMAP -0.29 0.00793 NA
101 hsa-miR-9-3p CCND2 1.69 0.12517 -2.81 0.0014 MirTarget; mirMAP; miRNATAP -0.14 0.00185 NA
102 hsa-miR-93-5p CCND2 2.66 0 -2.81 0.0014 miRNATAP -0.48 0 NA
103 hsa-miR-96-5p CCND2 5.63 0 -2.81 0.0014 TargetScan; miRNATAP -0.24 0.0003 NA
104 hsa-miR-27b-3p CCND3 -0.09 0.85847 -0.54 0.12437 miRNAWalker2 validate -0.14 0.00019 NA
105 hsa-miR-429 CCND3 6.4 0 -0.54 0.12437 miRNATAP -0.11 1.0E-5 NA
106 hsa-miR-96-5p CCND3 5.63 0 -0.54 0.12437 TargetScan -0.12 1.0E-5 NA
107 hsa-miR-582-5p CHP2 0.69 0.44776 1.48 0.50956 miRNATAP -0.42 0.00313 NA
108 hsa-miR-21-3p CREBBP 3.5 0 -0.4 0.18067 MirTarget -0.14 0 NA
109 hsa-miR-590-3p CREBBP 2.35 0 -0.4 0.18067 PITA; miRanda; mirMAP; miRNATAP -0.1 0.00219 NA
110 hsa-miR-186-5p CSNK1A1 0.45 0.18545 0.25 0.39557 miRNAWalker2 validate; miRNATAP -0.19 8.0E-5 NA
111 hsa-miR-30a-5p CSNK1A1 -0.77 0.32049 0.25 0.39557 MirTarget; miRNATAP -0.14 0 NA
112 hsa-miR-7-1-3p CSNK1A1 1.43 0.00471 0.25 0.39557 mirMAP -0.12 0.00016 NA
113 hsa-miR-125a-5p CSNK2A1 -1.32 0.00714 0.48 0.09134 MirTarget; PITA; miRanda -0.11 0.00094 NA
114 hsa-miR-342-3p CTBP2 1.31 0.02072 -0.53 0.12195 MirTarget; PITA; miRanda; miRNATAP -0.13 0.00023 NA
115 hsa-miR-150-5p CTNNB1 1.77 0.05938 -0.6 0.15222 MirTarget -0.12 0 NA
116 hsa-miR-155-5p CTNNB1 2.81 7.0E-5 -0.6 0.15222 miRNAWalker2 validate -0.17 0 NA
117 hsa-miR-221-3p CTNNB1 0.94 0.17475 -0.6 0.15222 miRNAWalker2 validate -0.15 1.0E-5 NA
118 hsa-miR-330-3p CTNNB1 2.49 0.00013 -0.6 0.15222 MirTarget; PITA; miRNATAP -0.11 0.00159 NA
119 hsa-miR-590-3p CTNNB1 2.35 0 -0.6 0.15222 miRanda -0.16 0.00059 NA
120 hsa-miR-10a-5p CTNNBIP1 -0.48 0.59461 1.03 0.01773 miRNATAP -0.13 0 NA
121 hsa-miR-125a-3p CTNNBIP1 -0.07 0.92074 1.03 0.01773 miRanda -0.17 0 NA
122 hsa-miR-125a-5p CTNNBIP1 -1.32 0.00714 1.03 0.01773 mirMAP -0.19 0.00017 NA
123 hsa-miR-192-5p CTNNBIP1 1.78 0.11349 1.03 0.01773 miRNAWalker2 validate; MirTarget; miRNATAP -0.13 0 NA
124 hsa-miR-215-5p CTNNBIP1 3.67 0.00295 1.03 0.01773 miRNAWalker2 validate; MirTarget -0.1 0 NA
125 hsa-miR-335-5p CTNNBIP1 0.17 0.8039 1.03 0.01773 miRNAWalker2 validate; mirMAP -0.16 1.0E-5 NA
126 hsa-miR-505-5p CTNNBIP1 -0.55 0.33141 1.03 0.01773 MirTarget -0.13 0.00352 NA
127 hsa-miR-625-5p CTNNBIP1 2.03 0.00094 1.03 0.01773 mirMAP -0.12 0.00286 NA
128 hsa-miR-92b-3p CTNNBIP1 1.69 0.01035 1.03 0.01773 miRNATAP -0.2 0 NA
129 hsa-let-7g-3p DAAM1 2.1 5.0E-5 0.28 0.67526 MirTarget -0.3 3.0E-5 NA
130 hsa-miR-125a-5p DAAM1 -1.32 0.00714 0.28 0.67526 MirTarget -0.28 0.00028 NA
131 hsa-miR-181c-5p DAAM1 -0.3 0.53753 0.28 0.67526 mirMAP -0.26 0.00068 NA
132 hsa-miR-186-5p DAAM1 0.45 0.18545 0.28 0.67526 MirTarget; mirMAP -0.54 0 NA
133 hsa-miR-194-5p DAAM1 0.69 0.52314 0.28 0.67526 miRNATAP -0.17 0 NA
134 hsa-miR-29b-3p DAAM1 0.67 0.23406 0.28 0.67526 MirTarget; miRNATAP -0.19 0.00398 NA
135 hsa-miR-29c-3p DAAM1 -0.41 0.52934 0.28 0.67526 MirTarget; miRNATAP -0.16 0.00523 NA
136 hsa-miR-32-5p DAAM1 2.93 0 0.28 0.67526 miRNATAP -0.22 0.00486 NA
137 hsa-miR-335-5p DAAM1 0.17 0.8039 0.28 0.67526 miRNAWalker2 validate; MirTarget; miRNATAP -0.19 0.0006 NA
138 hsa-miR-34a-5p DAAM1 0.83 0.04775 0.28 0.67526 MirTarget; miRNATAP -0.33 0.00028 NA
139 hsa-miR-362-3p DAAM1 0.68 0.22615 0.28 0.67526 MirTarget; miRanda; miRNATAP -0.21 0.00131 NA
140 hsa-miR-454-3p DAAM1 1.4 0.00366 0.28 0.67526 MirTarget; miRNATAP -0.24 0.00186 NA
141 hsa-miR-590-3p DAAM1 2.35 0 0.28 0.67526 MirTarget; miRanda; mirMAP -0.24 0.00087 NA
142 hsa-miR-92b-3p DAAM1 1.69 0.01035 0.28 0.67526 miRNATAP -0.18 0.00158 NA
143 hsa-miR-141-5p DAAM2 7.14 0 -4.26 1.0E-5 mirMAP -0.57 0 NA
144 hsa-miR-182-5p DAAM2 5.87 0 -4.26 1.0E-5 mirMAP -0.21 0.00366 NA
145 hsa-miR-18a-5p DAAM2 3.91 0 -4.26 1.0E-5 miRNAWalker2 validate -0.31 0.00023 NA
146 hsa-miR-193a-3p DAAM2 0.65 0.20713 -4.26 1.0E-5 miRanda -0.49 0 NA
147 hsa-miR-1976 DAAM2 3.27 0 -4.26 1.0E-5 mirMAP -0.55 0 NA
148 hsa-miR-205-5p DAAM2 8.08 0 -4.26 1.0E-5 mirMAP -0.19 0 NA
149 hsa-miR-339-5p DAAM2 1.23 0.03075 -4.26 1.0E-5 miRanda -0.4 2.0E-5 NA
150 hsa-miR-361-3p DAAM2 0.81 0.04185 -4.26 1.0E-5 mirMAP -0.67 0 NA
NumGOOverlapSizeP ValueAdj. P Value
1 WNT SIGNALING PATHWAY 64 351 1.612e-89 7.499e-86
2 CANONICAL WNT SIGNALING PATHWAY 37 95 3.752e-63 8.729e-60
3 NON CANONICAL WNT SIGNALING PATHWAY 33 140 1.23e-47 1.907e-44
4 REGULATION OF WNT SIGNALING PATHWAY 39 310 3.435e-45 3.996e-42
5 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 30 236 1.547e-34 1.439e-31
6 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 28 197 1.293e-33 1.002e-30
7 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 45 1021 3.893e-32 2.588e-29
8 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 53 1672 1.541e-31 8.962e-29
9 POSITIVE REGULATION OF RESPONSE TO STIMULUS 54 1929 1.562e-29 8.076e-27
10 REGULATION OF ORGAN MORPHOGENESIS 27 242 1.88e-29 8.748e-27
11 MORPHOGENESIS OF AN EPITHELIUM 31 400 6.239e-29 2.639e-26
12 POSITIVE REGULATION OF GENE EXPRESSION 51 1733 1.38e-28 5.351e-26
13 TISSUE MORPHOGENESIS 33 533 1.108e-27 3.965e-25
14 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 23 162 1.373e-27 4.563e-25
15 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 47 1492 2.922e-27 9.063e-25
16 EPITHELIUM DEVELOPMENT 39 945 2.162e-26 6.287e-24
17 ORGAN MORPHOGENESIS 37 841 6.524e-26 1.786e-23
18 POSITIVE REGULATION OF CELL COMMUNICATION 46 1532 1.043e-25 2.696e-23
19 WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY 15 39 1.678e-25 4.109e-23
20 TISSUE DEVELOPMENT 45 1518 7.697e-25 1.791e-22
21 REGULATION OF PROTEIN MODIFICATION PROCESS 47 1710 1.081e-24 2.396e-22
22 TUBE MORPHOGENESIS 26 323 1.262e-24 2.668e-22
23 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY 19 110 1.389e-24 2.81e-22
24 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 47 1805 1.095e-23 2.039e-21
25 REGULATION OF PHOSPHORUS METABOLIC PROCESS 45 1618 1.069e-23 2.039e-21
26 TUBE DEVELOPMENT 30 552 1.938e-23 3.468e-21
27 REGULATION OF CELL DIFFERENTIATION 43 1492 4.104e-23 7.073e-21
28 BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY 12 22 5.923e-23 9.842e-21
29 EMBRYONIC MORPHOGENESIS 29 539 1.611e-22 2.584e-20
30 CARDIOVASCULAR SYSTEM DEVELOPMENT 33 788 2.699e-22 4.05e-20
31 CIRCULATORY SYSTEM DEVELOPMENT 33 788 2.699e-22 4.05e-20
32 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 37 1135 2.115e-21 3.075e-19
33 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 37 1142 2.607e-21 3.675e-19
34 POSITIVE REGULATION OF MOLECULAR FUNCTION 44 1791 5.863e-21 8.023e-19
35 REGULATION OF EMBRYONIC DEVELOPMENT 17 114 6.397e-21 8.504e-19
36 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 35 1036 1.142e-20 1.398e-18
37 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 35 1036 1.142e-20 1.398e-18
38 NEGATIVE REGULATION OF CELL COMMUNICATION 37 1192 1.115e-20 1.398e-18
39 EMBRYO DEVELOPMENT 33 894 1.331e-20 1.588e-18
40 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 39 1395 2.807e-20 3.265e-18
41 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 33 957 1.064e-19 1.179e-17
42 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 38 1360 1.051e-19 1.179e-17
43 POSITIVE REGULATION OF CELL DIFFERENTIATION 31 823 1.459e-19 1.579e-17
44 PATTERN SPECIFICATION PROCESS 24 418 2.784e-19 2.944e-17
45 NEURON DIFFERENTIATION 31 874 8.193e-19 8.472e-17
46 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 26 554 1.066e-18 1.079e-16
47 CELL FATE COMMITMENT 19 227 2.035e-18 2.015e-16
48 NEUROGENESIS 37 1402 2.53e-18 2.452e-16
49 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 16 134 3.917e-18 3.72e-16
50 CELL PROLIFERATION 27 672 1.049e-17 9.766e-16
51 SENSORY ORGAN DEVELOPMENT 24 493 1.235e-17 1.127e-15
52 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 16 152 3.077e-17 2.753e-15
53 REGIONALIZATION 20 311 4.251e-17 3.732e-15
54 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 21 365 6.11e-17 5.265e-15
55 ANTERIOR POSTERIOR PATTERN SPECIFICATION 17 194 6.744e-17 5.706e-15
56 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 28 801 8.468e-17 7.036e-15
57 REGULATION OF CELL PROLIFERATION 36 1496 1.618e-16 1.321e-14
58 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 39 1848 4.524e-16 3.629e-14
59 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 37 1656 5.724e-16 4.514e-14
60 HEART DEVELOPMENT 22 466 6.412e-16 4.973e-14
61 REGULATION OF CELL CYCLE 29 949 7.274e-16 5.459e-14
62 REGULATION OF CELL DEATH 35 1472 7.172e-16 5.459e-14
63 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 38 1784 9.391e-16 6.936e-14
64 STEM CELL DIFFERENTIATION 16 190 1.116e-15 8.112e-14
65 CELL DEVELOPMENT 34 1426 1.984e-15 1.42e-13
66 TUBE FORMATION 14 129 2.163e-15 1.525e-13
67 EPITHELIAL TO MESENCHYMAL TRANSITION 11 56 2.724e-15 1.892e-13
68 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 29 1004 3.15e-15 2.156e-13
69 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 34 1517 1.229e-14 8.288e-13
70 POSITIVE REGULATION OF CATALYTIC ACTIVITY 34 1518 1.253e-14 8.329e-13
71 NEURAL TUBE DEVELOPMENT 14 149 1.664e-14 1.091e-12
72 REGULATION OF CELLULAR PROTEIN LOCALIZATION 22 552 2.093e-14 1.353e-12
73 REGULATION OF CELLULAR RESPONSE TO STRESS 24 691 2.337e-14 1.49e-12
74 REGULATION OF RESPONSE TO STRESS 33 1468 3.175e-14 1.997e-12
75 NEURAL TUBE FORMATION 12 94 3.283e-14 2.037e-12
76 REGULATION OF KINASE ACTIVITY 25 776 3.343e-14 2.047e-12
77 REGULATION OF BINDING 17 283 3.697e-14 2.234e-12
78 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 15 197 4.159e-14 2.419e-12
79 REGULATION OF JNK CASCADE 14 159 4.138e-14 2.419e-12
80 SENSORY ORGAN MORPHOGENESIS 16 239 4.151e-14 2.419e-12
81 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 18 337 4.626e-14 2.657e-12
82 REGULATION OF TRANSFERASE ACTIVITY 27 946 4.735e-14 2.687e-12
83 NEGATIVE REGULATION OF GENE EXPRESSION 33 1493 5.125e-14 2.873e-12
84 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 21 513 5.297e-14 2.899e-12
85 REGULATION OF PROTEIN LOCALIZATION 27 950 5.239e-14 2.899e-12
86 MORPHOGENESIS OF A BRANCHING STRUCTURE 14 167 8.206e-14 4.44e-12
87 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 29 1152 1.066e-13 5.666e-12
88 VASCULATURE DEVELOPMENT 20 469 1.072e-13 5.666e-12
89 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 27 983 1.185e-13 6.198e-12
90 SOMITE DEVELOPMENT 11 78 1.303e-13 6.736e-12
91 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE 7 14 1.82e-13 9.204e-12
92 CONVERGENT EXTENSION 7 14 1.82e-13 9.204e-12
93 CELL ACTIVATION 21 568 3.807e-13 1.905e-11
94 SOMITOGENESIS 10 62 4.342e-13 2.149e-11
95 MESENCHYME DEVELOPMENT 14 190 4.891e-13 2.395e-11
96 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 25 876 5.03e-13 2.438e-11
97 SEGMENTATION 11 89 5.854e-13 2.804e-11
98 POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 12 119 5.905e-13 2.804e-11
99 GASTRULATION 13 155 6.665e-13 3.132e-11
100 GLAND DEVELOPMENT 18 395 6.912e-13 3.216e-11
101 CELLULAR RESPONSE TO RETINOIC ACID 10 65 7.142e-13 3.29e-11
102 REGULATION OF MAPK CASCADE 22 660 7.647e-13 3.488e-11
103 EMBRYONIC ORGAN DEVELOPMENT 18 406 1.098e-12 4.96e-11
104 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 19 470 1.225e-12 5.481e-11
105 POSITIVE REGULATION OF CELL DEATH 21 605 1.275e-12 5.652e-11
106 INTRACELLULAR SIGNAL TRANSDUCTION 32 1572 1.316e-12 5.776e-11
107 REGULATION OF CELLULAR LOCALIZATION 29 1277 1.408e-12 6.124e-11
108 NEGATIVE REGULATION OF CELL DIFFERENTIATION 21 609 1.446e-12 6.231e-11
109 RESPONSE TO OXYGEN CONTAINING COMPOUND 30 1381 1.605e-12 6.851e-11
110 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 12 131 1.882e-12 7.961e-11
111 HEART MORPHOGENESIS 14 212 2.19e-12 9.179e-11
112 MESENCHYMAL CELL DIFFERENTIATION 12 134 2.47e-12 1.026e-10
113 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 12 135 2.7e-12 1.112e-10
114 NEGATIVE REGULATION OF CELL DEATH 24 872 3.477e-12 1.419e-10
115 DORSAL VENTRAL AXIS SPECIFICATION 7 20 4.014e-12 1.624e-10
116 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 23 799 4.308e-12 1.728e-10
117 EYE DEVELOPMENT 16 326 4.878e-12 1.94e-10
118 POSITIVE REGULATION OF CELL PROLIFERATION 23 814 6.286e-12 2.479e-10
119 EMBRYONIC ORGAN MORPHOGENESIS 15 279 6.564e-12 2.567e-10
120 REGULATION OF JUN KINASE ACTIVITY 10 81 7.028e-12 2.725e-10
121 NEGATIVE REGULATION OF MOLECULAR FUNCTION 26 1079 7.27e-12 2.796e-10
122 CELLULAR RESPONSE TO LIPID 18 457 7.924e-12 3.022e-10
123 POSITIVE REGULATION OF MAPK CASCADE 18 470 1.261e-11 4.768e-10
124 REPRODUCTIVE SYSTEM DEVELOPMENT 17 408 1.331e-11 4.995e-10
125 RESPONSE TO GROWTH FACTOR 18 475 1.501e-11 5.588e-10
126 REGULATION OF CELL MORPHOGENESIS 19 552 2.008e-11 7.414e-10
127 AXIS SPECIFICATION 10 90 2.064e-11 7.564e-10
128 REGULATION OF HYDROLASE ACTIVITY 28 1327 2.178e-11 7.919e-10
129 BETA CATENIN TCF COMPLEX ASSEMBLY 8 43 3.128e-11 1.128e-09
130 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 7 26 3.325e-11 1.19e-09
131 RESPONSE TO LIPID 23 888 3.623e-11 1.287e-09
132 APPENDAGE DEVELOPMENT 12 169 3.873e-11 1.355e-09
133 LIMB DEVELOPMENT 12 169 3.873e-11 1.355e-09
134 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 15 323 5.236e-11 1.818e-09
135 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 21 740 5.61e-11 1.934e-09
136 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 13 220 5.708e-11 1.953e-09
137 DOPAMINERGIC NEURON DIFFERENTIATION 7 28 5.938e-11 2.017e-09
138 POSITIVE REGULATION OF CELL CYCLE 15 332 7.701e-11 2.585e-09
139 REGULATION OF CELL DEVELOPMENT 22 836 7.722e-11 2.585e-09
140 DIGESTIVE TRACT MORPHOGENESIS 8 48 7.978e-11 2.652e-09
141 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 13 228 8.91e-11 2.94e-09
142 MACROMOLECULAR COMPLEX DISASSEMBLY 12 182 9.213e-11 3.019e-09
143 REGULATION OF PROTEIN IMPORT 12 183 9.82e-11 3.195e-09
144 RESPONSE TO RETINOIC ACID 10 107 1.184e-10 3.827e-09
145 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 11 144 1.202e-10 3.832e-09
146 REGULATION OF CELLULAR COMPONENT MOVEMENT 21 771 1.195e-10 3.832e-09
147 MAMMARY GLAND EPITHELIUM DEVELOPMENT 8 53 1.837e-10 5.814e-09
148 REGULATION OF OSTEOBLAST DIFFERENTIATION 10 112 1.87e-10 5.878e-09
149 HEAD DEVELOPMENT 20 709 1.921e-10 6e-09
150 REGULATION OF STEM CELL DIFFERENTIATION 10 113 2.043e-10 6.337e-09
151 RHYTHMIC PROCESS 14 298 2.083e-10 6.42e-09
152 UROGENITAL SYSTEM DEVELOPMENT 14 299 2.177e-10 6.664e-09
153 KIDNEY MORPHOGENESIS 9 82 2.442e-10 7.428e-09
154 REGULATION OF TRANSPORT 31 1804 2.48e-10 7.492e-09
155 REGULATION OF MESENCHYMAL CELL PROLIFERATION 7 34 2.634e-10 7.907e-09
156 NEGATIVE REGULATION OF CELL PROLIFERATION 19 643 2.687e-10 8.015e-09
157 BLOOD VESSEL MORPHOGENESIS 15 364 2.777e-10 8.232e-09
158 REGULATION OF PROTEIN TARGETING 14 307 3.077e-10 9.063e-09
159 CELLULAR COMPONENT MORPHOGENESIS 22 900 3.136e-10 9.176e-09
160 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 11 162 4.273e-10 1.242e-08
161 REGULATION OF STEM CELL PROLIFERATION 9 88 4.649e-10 1.343e-08
162 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 20 750 5.131e-10 1.474e-08
163 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 15 381 5.22e-10 1.49e-08
164 MIDBRAIN DEVELOPMENT 9 90 5.7e-10 1.617e-08
165 EMBRYONIC DIGIT MORPHOGENESIS 8 61 5.91e-10 1.667e-08
166 DORSAL VENTRAL PATTERN FORMATION 9 91 6.3e-10 1.766e-08
167 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 12 218 7.406e-10 2.064e-08
168 CELL CELL SIGNALING 20 767 7.57e-10 2.097e-08
169 PROTEIN PHOSPHORYLATION 22 944 7.681e-10 2.11e-08
170 POSITIVE REGULATION OF JUN KINASE ACTIVITY 8 63 7.71e-10 2.11e-08
171 DEVELOPMENTAL GROWTH 14 333 8.872e-10 2.414e-08
172 CELLULAR RESPONSE TO ACID CHEMICAL 11 175 9.733e-10 2.633e-08
173 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 18 616 1.009e-09 2.714e-08
174 POSITIVE REGULATION OF CELL DEVELOPMENT 16 472 1.154e-09 3.086e-08
175 REGULATION OF OSSIFICATION 11 178 1.166e-09 3.1e-08
176 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 8 67 1.278e-09 3.359e-08
177 EYE MORPHOGENESIS 10 136 1.275e-09 3.359e-08
178 REGULATION OF EPITHELIAL CELL PROLIFERATION 13 285 1.386e-09 3.624e-08
179 REGULATION OF CYTOPLASMIC TRANSPORT 16 481 1.514e-09 3.936e-08
180 POSITIVE REGULATION OF KINASE ACTIVITY 16 482 1.56e-09 4.033e-08
181 CAMERA TYPE EYE MORPHOGENESIS 9 101 1.613e-09 4.146e-08
182 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 13 289 1.642e-09 4.198e-08
183 REGULATION OF ORGANELLE ORGANIZATION 24 1178 1.655e-09 4.207e-08
184 REGULATION OF CELL CYCLE PROCESS 17 558 1.666e-09 4.213e-08
185 FC EPSILON RECEPTOR SIGNALING PATHWAY 10 142 1.945e-09 4.893e-08
186 REGULATION OF IMMUNE SYSTEM PROCESS 26 1403 2.194e-09 5.489e-08
187 CELL DEATH 22 1001 2.28e-09 5.673e-08
188 IMMUNE SYSTEM PROCESS 31 1984 2.557e-09 6.328e-08
189 PROTEIN COMPLEX SUBUNIT ORGANIZATION 27 1527 2.743e-09 6.753e-08
190 MUSCLE STRUCTURE DEVELOPMENT 15 432 2.904e-09 7.113e-08
191 LOCOMOTION 23 1114 3.028e-09 7.376e-08
192 IMMUNE SYSTEM DEVELOPMENT 17 582 3.136e-09 7.599e-08
193 DEVELOPMENTAL INDUCTION 6 27 3.229e-09 7.704e-08
194 REGULATION OF CATENIN IMPORT INTO NUCLEUS 6 27 3.229e-09 7.704e-08
195 AXIS ELONGATION 6 27 3.229e-09 7.704e-08
196 RESPONSE TO ABIOTIC STIMULUS 22 1024 3.463e-09 8.22e-08
197 CELLULAR COMPONENT DISASSEMBLY 16 515 4.019e-09 9.492e-08
198 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 10 154 4.282e-09 1.006e-07
199 RESPONSE TO ENDOGENOUS STIMULUS 26 1450 4.377e-09 1.024e-07
200 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 7 50 4.588e-09 1.067e-07
201 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 17 602 5.191e-09 1.202e-07
202 REGULATION OF MAP KINASE ACTIVITY 13 319 5.4e-09 1.244e-07
203 SKELETAL SYSTEM DEVELOPMENT 15 455 5.847e-09 1.34e-07
204 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 9 117 5.981e-09 1.357e-07
205 MAMMARY GLAND DEVELOPMENT 9 117 5.981e-09 1.357e-07
206 POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS 12 263 6.204e-09 1.401e-07
207 CELLULAR RESPONSE TO EXTERNAL STIMULUS 12 264 6.474e-09 1.455e-07
208 SINGLE ORGANISM CELL ADHESION 15 459 6.576e-09 1.471e-07
209 REGULATION OF CELL GROWTH 14 391 6.957e-09 1.549e-07
210 REGULATION OF PROTEIN CATABOLIC PROCESS 14 393 7.422e-09 1.644e-07
211 REGULATION OF INTRACELLULAR TRANSPORT 17 621 8.231e-09 1.815e-07
212 REGULATION OF MITOTIC CELL CYCLE 15 468 8.531e-09 1.872e-07
213 CELL CYCLE PROCESS 22 1081 9.292e-09 2.03e-07
214 REGULATION OF PROTEIN BINDING 10 168 9.91e-09 2.155e-07
215 OUTFLOW TRACT MORPHOGENESIS 7 56 1.04e-08 2.251e-07
216 KIDNEY EPITHELIUM DEVELOPMENT 9 125 1.072e-08 2.31e-07
217 REGULATION OF GROWTH 17 633 1.092e-08 2.341e-07
218 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 14 406 1.12e-08 2.391e-07
219 LYMPHOCYTE ACTIVATION 13 342 1.239e-08 2.632e-07
220 GROWTH 14 410 1.267e-08 2.681e-07
221 EMBRYONIC PATTERN SPECIFICATION 7 58 1.338e-08 2.817e-07
222 MESONEPHROS DEVELOPMENT 8 90 1.385e-08 2.903e-07
223 LEUKOCYTE ACTIVATION 14 414 1.432e-08 2.959e-07
224 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 6 34 1.427e-08 2.959e-07
225 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 21 1008 1.437e-08 2.959e-07
226 BRAIN MORPHOGENESIS 6 34 1.427e-08 2.959e-07
227 CELL CYCLE 24 1316 1.444e-08 2.959e-07
228 STEM CELL PROLIFERATION 7 60 1.705e-08 3.479e-07
229 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 16 573 1.807e-08 3.656e-07
230 EPITHELIAL CELL DIFFERENTIATION 15 495 1.801e-08 3.656e-07
231 ANGIOGENESIS 12 293 2.065e-08 4.16e-07
232 RESPONSE TO DRUG 14 431 2.372e-08 4.758e-07
233 REGULATION OF MUSCLE ADAPTATION 7 63 2.413e-08 4.819e-07
234 REGULATION OF IMMUNE RESPONSE 19 858 3.006e-08 5.977e-07
235 REGULATION OF CELLULAR COMPONENT BIOGENESIS 18 767 3.049e-08 6.037e-07
236 LENS DEVELOPMENT IN CAMERA TYPE EYE 7 66 3.356e-08 6.617e-07
237 CENTRAL NERVOUS SYSTEM DEVELOPMENT 19 872 3.884e-08 7.626e-07
238 CONNECTIVE TISSUE DEVELOPMENT 10 194 3.907e-08 7.638e-07
239 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 8 104 4.351e-08 8.471e-07
240 RESPIRATORY SYSTEM DEVELOPMENT 10 197 4.517e-08 8.756e-07
241 PEPTIDYL SERINE MODIFICATION 9 148 4.684e-08 9.006e-07
242 DIGESTIVE SYSTEM DEVELOPMENT 9 148 4.684e-08 9.006e-07
243 COCHLEA MORPHOGENESIS 5 21 4.873e-08 9.33e-07
244 LEUKOCYTE CELL CELL ADHESION 11 255 4.917e-08 9.377e-07
245 RESPONSE TO ACID CHEMICAL 12 319 5.261e-08 9.991e-07
246 REGULATION OF CELL ADHESION 16 629 6.565e-08 1.242e-06
247 CELLULAR RESPONSE TO ABIOTIC STIMULUS 11 263 6.734e-08 1.269e-06
248 FC RECEPTOR SIGNALING PATHWAY 10 206 6.88e-08 1.291e-06
249 POSITIVE REGULATION OF HYDROLASE ACTIVITY 19 905 6.971e-08 1.303e-06
250 POSITIVE REGULATION OF MAP KINASE ACTIVITY 10 207 7.2e-08 1.34e-06
251 SEX DIFFERENTIATION 11 266 7.556e-08 1.401e-06
252 SKIN DEVELOPMENT 10 211 8.617e-08 1.591e-06
253 REGULATION OF CATABOLIC PROCESS 17 731 8.844e-08 1.627e-06
254 PHOSPHORYLATION 22 1228 8.995e-08 1.648e-06
255 REGULATION OF CELLULAR RESPONSE TO HEAT 7 76 9.054e-08 1.652e-06
256 PEPTIDYL THREONINE MODIFICATION 6 46 9.479e-08 1.723e-06
257 NEPHRON DEVELOPMENT 8 115 9.561e-08 1.731e-06
258 RENAL TUBULE DEVELOPMENT 7 78 1.085e-07 1.958e-06
259 BIOLOGICAL ADHESION 20 1032 1.1e-07 1.977e-06
260 ANTERIOR POSTERIOR AXIS SPECIFICATION 6 48 1.232e-07 2.205e-06
261 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 8 121 1.42e-07 2.531e-06
262 NEGATIVE REGULATION OF CELL GROWTH 9 170 1.542e-07 2.739e-06
263 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 28 1977 1.578e-07 2.792e-06
264 FOREBRAIN DEVELOPMENT 12 357 1.783e-07 3.143e-06
265 REGULATION OF CELL SUBSTRATE ADHESION 9 173 1.79e-07 3.143e-06
266 POSITIVE REGULATION OF OSSIFICATION 7 84 1.817e-07 3.178e-06
267 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 10 229 1.849e-07 3.222e-06
268 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 5 27 1.889e-07 3.279e-06
269 PALATE DEVELOPMENT 7 85 1.972e-07 3.411e-06
270 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 16 684 2.052e-07 3.536e-06
271 RESPONSE TO ALCOHOL 12 362 2.071e-07 3.556e-06
272 MESONEPHRIC TUBULE MORPHOGENESIS 6 53 2.26e-07 3.866e-06
273 GASTRULATION WITH MOUTH FORMING SECOND 5 28 2.29e-07 3.904e-06
274 NEGATIVE REGULATION OF GROWTH 10 236 2.444e-07 4.15e-06
275 NEGATIVE REGULATION OF BINDING 8 131 2.622e-07 4.437e-06
276 POSITIVE REGULATION OF GROWTH 10 238 2.642e-07 4.454e-06
277 EPITHELIAL CELL PROLIFERATION 7 89 2.709e-07 4.551e-06
278 INNER EAR MORPHOGENESIS 7 92 3.404e-07 5.697e-06
279 REGULATION OF PROTEOLYSIS 16 711 3.45e-07 5.753e-06
280 RESPONSE TO CYTOKINE 16 714 3.649e-07 6.064e-06
281 NEPHRON EPITHELIUM DEVELOPMENT 7 93 3.666e-07 6.071e-06
282 POSITIVE REGULATION OF CELL CYCLE PROCESS 10 247 3.72e-07 6.13e-06
283 CELLULAR RESPONSE TO STRESS 24 1565 3.728e-07 6.13e-06
284 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 14 541 3.855e-07 6.295e-06
285 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 14 541 3.855e-07 6.295e-06
286 RESPONSE TO EXTERNAL STIMULUS 26 1821 4.295e-07 6.988e-06
287 RESPONSE TO ORGANIC CYCLIC COMPOUND 18 917 4.366e-07 7.078e-06
288 PATTERNING OF BLOOD VESSELS 5 32 4.621e-07 7.465e-06
289 CELL MIGRATION INVOLVED IN GASTRULATION 4 14 5.225e-07 8.412e-06
290 POSITIVE REGULATION OF CATABOLIC PROCESS 12 395 5.249e-07 8.423e-06
291 POSITIVE REGULATION OF STEM CELL PROLIFERATION 6 61 5.296e-07 8.468e-06
292 CARDIAC CHAMBER DEVELOPMENT 8 144 5.414e-07 8.585e-06
293 EMBRYONIC AXIS SPECIFICATION 5 33 5.425e-07 8.585e-06
294 POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT 5 33 5.425e-07 8.585e-06
295 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 10 258 5.547e-07 8.749e-06
296 CELL MOTILITY 17 835 5.77e-07 9.04e-06
297 LOCALIZATION OF CELL 17 835 5.77e-07 9.04e-06
298 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 9 199 5.848e-07 9.131e-06
299 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 7 100 6.025e-07 9.376e-06
300 RESPONSE TO INORGANIC SUBSTANCE 13 479 6.113e-07 9.481e-06
301 SKELETAL SYSTEM MORPHOGENESIS 9 201 6.359e-07 9.831e-06
302 REGULATION OF CARTILAGE DEVELOPMENT 6 63 6.43e-07 9.906e-06
303 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 12 404 6.66e-07 1.021e-05
304 MALE SEX DIFFERENTIATION 8 148 6.67e-07 1.021e-05
305 RESPONSE TO METAL ION 11 333 7.131e-07 1.088e-05
306 BONE REMODELING 5 35 7.363e-07 1.12e-05
307 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 21 1275 7.468e-07 1.132e-05
308 CARDIAC CHAMBER MORPHOGENESIS 7 104 7.869e-07 1.189e-05
309 PROTEASOMAL PROTEIN CATABOLIC PROCESS 10 271 8.681e-07 1.307e-05
310 REGULATION OF FAT CELL DIFFERENTIATION 7 106 8.956e-07 1.34e-05
311 FAT CELL DIFFERENTIATION 7 106 8.956e-07 1.34e-05
312 MITOTIC CELL CYCLE 16 766 9.254e-07 1.38e-05
313 PARAXIAL MESODERM DEVELOPMENT 4 16 9.429e-07 1.397e-05
314 APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 4 16 9.429e-07 1.397e-05
315 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 17 867 9.699e-07 1.433e-05
316 REPRODUCTION 21 1297 9.851e-07 1.451e-05
317 POSITIVE REGULATION OF LOCOMOTION 12 420 1.002e-06 1.471e-05
318 REGULATION OF CELL JUNCTION ASSEMBLY 6 68 1.016e-06 1.483e-05
319 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 7 108 1.017e-06 1.483e-05
320 NEGATIVE REGULATION OF PHOSPHORYLATION 12 422 1.053e-06 1.531e-05
321 MESENCHYME MORPHOGENESIS 5 38 1.125e-06 1.631e-05
322 FORMATION OF PRIMARY GERM LAYER 7 110 1.151e-06 1.663e-05
323 NEURAL PRECURSOR CELL PROLIFERATION 6 70 1.207e-06 1.739e-05
324 REGULATION OF CHROMATIN BINDING 4 17 1.228e-06 1.753e-05
325 ESTABLISHMENT OF TISSUE POLARITY 4 17 1.228e-06 1.753e-05
326 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 4 17 1.228e-06 1.753e-05
327 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 10 282 1.245e-06 1.771e-05
328 COCHLEA DEVELOPMENT 5 39 1.286e-06 1.824e-05
329 EAR MORPHOGENESIS 7 112 1.3e-06 1.838e-05
330 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 13 514 1.344e-06 1.895e-05
331 NEGATIVE REGULATION OF CELL CYCLE 12 433 1.378e-06 1.936e-05
332 RESPONSE TO HORMONE 17 893 1.453e-06 2.037e-05
333 POSITIVE REGULATION OF CELL MATRIX ADHESION 5 40 1.464e-06 2.045e-05
334 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 11 360 1.527e-06 2.128e-05
335 REGULATION OF DEVELOPMENTAL GROWTH 10 289 1.552e-06 2.138e-05
336 CELL CELL ADHESION 14 608 1.542e-06 2.138e-05
337 EMBRYONIC HEART TUBE DEVELOPMENT 6 73 1.549e-06 2.138e-05
338 RESPONSE TO CALCIUM ION 7 115 1.553e-06 2.138e-05
339 POST ANAL TAIL MORPHOGENESIS 4 18 1.573e-06 2.16e-05
340 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 8 166 1.588e-06 2.173e-05
341 POSITIVE REGULATION OF PROTEOLYSIS 11 363 1.656e-06 2.252e-05
342 REGULATION OF APOPTOTIC SIGNALING PATHWAY 11 363 1.656e-06 2.252e-05
343 RESPONSE TO EXTRACELLULAR STIMULUS 12 441 1.666e-06 2.261e-05
344 LEUKOCYTE DIFFERENTIATION 10 292 1.703e-06 2.304e-05
345 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 4 19 1.985e-06 2.678e-05
346 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 11 370 1.992e-06 2.679e-05
347 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 5 43 2.117e-06 2.83e-05
348 MORPHOGENESIS OF AN EPITHELIAL SHEET 5 43 2.117e-06 2.83e-05
349 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 6 77 2.123e-06 2.831e-05
350 NEGATIVE REGULATION OF CELL DEVELOPMENT 10 303 2.373e-06 3.144e-05
351 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 5 44 2.379e-06 3.144e-05
352 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 10 303 2.373e-06 3.144e-05
353 NEGATIVE REGULATION OF PROTEIN BINDING 6 79 2.47e-06 3.223e-05
354 NEGATIVE REGULATION OF TRANSPORT 12 458 2.465e-06 3.223e-05
355 TRACHEA DEVELOPMENT 4 20 2.473e-06 3.223e-05
356 POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 4 20 2.473e-06 3.223e-05
357 BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 4 20 2.473e-06 3.223e-05
358 MUSCLE CELL DIFFERENTIATION 9 237 2.493e-06 3.24e-05
359 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 16 829 2.584e-06 3.349e-05
360 THYMOCYTE AGGREGATION 5 45 2.666e-06 3.436e-05
361 T CELL DIFFERENTIATION IN THYMUS 5 45 2.666e-06 3.436e-05
362 OSTEOBLAST DIFFERENTIATION 7 126 2.865e-06 3.673e-05
363 REGULATION OF FIBROBLAST PROLIFERATION 6 81 2.861e-06 3.673e-05
364 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 12 465 2.881e-06 3.683e-05
365 REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 8 181 3.031e-06 3.858e-05
366 APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 4 21 3.043e-06 3.858e-05
367 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 4 21 3.043e-06 3.858e-05
368 REGULATION OF NEURON DIFFERENTIATION 13 554 3.068e-06 3.879e-05
369 REGULATION OF ACTIN FILAMENT BASED PROCESS 10 312 3.08e-06 3.883e-05
370 HEPATICOBILIARY SYSTEM DEVELOPMENT 7 128 3.182e-06 3.991e-05
371 REGULATION OF PHOSPHATASE ACTIVITY 7 128 3.182e-06 3.991e-05
372 WOUND HEALING 12 470 3.215e-06 4.022e-05
373 REGULATION OF CELL PROJECTION ORGANIZATION 13 558 3.319e-06 4.14e-05
374 REGULATION OF CYTOKINE PRODUCTION 13 563 3.657e-06 4.538e-05
375 RESPONSE TO WOUNDING 13 563 3.657e-06 4.538e-05
376 POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 5 48 3.693e-06 4.57e-05
377 SOMATIC STEM CELL DIVISION 4 22 3.705e-06 4.573e-05
378 CARDIAC SEPTUM DEVELOPMENT 6 85 3.795e-06 4.671e-05
379 NEGATIVE REGULATION OF KINASE ACTIVITY 9 250 3.857e-06 4.736e-05
380 MAINTENANCE OF CELL NUMBER 7 132 3.905e-06 4.782e-05
381 CARDIAC SEPTUM MORPHOGENESIS 5 49 4.097e-06 5.003e-05
382 G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 19 1193 4.514e-06 5.499e-05
383 REGULATION OF ADHERENS JUNCTION ORGANIZATION 5 50 4.534e-06 5.508e-05
384 PROTEIN AUTOPHOSPHORYLATION 8 192 4.692e-06 5.685e-05
385 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 18 1087 4.906e-06 5.929e-05
386 POSITIVE REGULATION OF FAT CELL DIFFERENTIATION 5 51 5.008e-06 6.021e-05
387 REGULATION OF GTPASE ACTIVITY 14 673 5.003e-06 6.021e-05
388 REGULATION OF CELL MATRIX ADHESION 6 90 5.297e-06 6.353e-05
389 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 4 24 5.342e-06 6.373e-05
390 REGULATION OF PROTEIN PHOSPHATASE TYPE 2A ACTIVITY 4 24 5.342e-06 6.373e-05
391 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 9 262 5.644e-06 6.716e-05
392 NEGATIVE REGULATION OF LOCOMOTION 9 263 5.82e-06 6.908e-05
393 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 7 141 6.041e-06 7.153e-05
394 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 5 53 6.07e-06 7.169e-05
395 REGULATION OF CYTOSKELETON ORGANIZATION 12 502 6.29e-06 7.409e-05
396 SYNAPSE ORGANIZATION 7 145 7.263e-06 8.534e-05
397 REGULATION OF KIDNEY DEVELOPMENT 5 55 7.302e-06 8.558e-05
398 DEVELOPMENTAL PROGRAMMED CELL DEATH 4 26 7.459e-06 8.72e-05
399 REGULATION OF CELL DIVISION 9 272 7.634e-06 8.903e-05
400 CARTILAGE DEVELOPMENT 7 147 7.947e-06 9.244e-05
401 REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 7 148 8.308e-06 9.616e-05
402 POSITIVE REGULATION OF CELL GROWTH 7 148 8.308e-06 9.616e-05
403 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 8 209 8.746e-06 0.0001005
404 RESPONSE TO LITHIUM ION 4 27 8.724e-06 0.0001005
405 LYMPHOCYTE DIFFERENTIATION 8 209 8.746e-06 0.0001005
406 REGULATION OF CHROMOSOME ORGANIZATION 9 278 9.096e-06 0.0001042
407 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 13 616 9.64e-06 0.0001102
408 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 11 437 9.714e-06 0.0001108
409 VENTRICULAR SEPTUM MORPHOGENESIS 4 28 1.014e-05 0.0001148
410 MORPHOGENESIS OF A POLARIZED EPITHELIUM 4 28 1.014e-05 0.0001148
411 MAMMARY GLAND DUCT MORPHOGENESIS 4 28 1.014e-05 0.0001148
412 PALLIUM DEVELOPMENT 7 153 1.033e-05 0.0001166
413 VASCULOGENESIS 5 59 1.035e-05 0.0001166
414 AMEBOIDAL TYPE CELL MIGRATION 7 154 1.078e-05 0.0001211
415 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 8 216 1.112e-05 0.0001247
416 REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 5 60 1.124e-05 0.0001255
417 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 5 60 1.124e-05 0.0001255
418 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 14 724 1.145e-05 0.0001275
419 REGULATION OF MUSCLE TISSUE DEVELOPMENT 6 103 1.156e-05 0.0001277
420 REGULATION OF MUSCLE ORGAN DEVELOPMENT 6 103 1.156e-05 0.0001277
421 STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 6 103 1.156e-05 0.0001277
422 STEM CELL DIVISION 4 29 1.172e-05 0.0001289
423 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 7 156 1.172e-05 0.0001289
424 POSITIVE REGULATION OF TRANSPORT 16 936 1.198e-05 0.0001315
425 POSITIVE REGULATION OF PROTEIN IMPORT 6 104 1.222e-05 0.0001338
426 REGULATION OF DEPHOSPHORYLATION 7 158 1.274e-05 0.0001391
427 CEREBRAL CORTEX DEVELOPMENT 6 105 1.291e-05 0.0001406
428 REGULATION OF PROTEIN STABILITY 8 221 1.313e-05 0.0001427
429 REGULATION OF SMOOTHENED SIGNALING PATHWAY 5 62 1.322e-05 0.000143
430 EMBRYONIC HEART TUBE MORPHOGENESIS 5 62 1.322e-05 0.000143
431 INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 6 106 1.363e-05 0.0001471
432 POSITIVE REGULATION OF CYTOKINE PRODUCTION 10 370 1.373e-05 0.0001479
433 REGULATION OF EPIDERMIS DEVELOPMENT 5 63 1.43e-05 0.0001537
434 REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 4 31 1.541e-05 0.0001652
435 POSITIVE REGULATION OF CELL ADHESION 10 376 1.577e-05 0.0001687
436 TELENCEPHALON DEVELOPMENT 8 228 1.645e-05 0.0001755
437 REGULATION OF ORGAN FORMATION 4 32 1.754e-05 0.0001864
438 EMBRYONIC FORELIMB MORPHOGENESIS 4 32 1.754e-05 0.0001864
439 SOMATIC STEM CELL POPULATION MAINTENANCE 5 66 1.798e-05 0.0001901
440 MESODERM MORPHOGENESIS 5 66 1.798e-05 0.0001901
441 POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 3 11 1.83e-05 0.000193
442 REGULATION OF VASCULATURE DEVELOPMENT 8 233 1.923e-05 0.0002024
443 POSITIVE REGULATION OF IMMUNE RESPONSE 12 563 1.978e-05 0.0002077
444 CELLULAR RESPONSE TO ALCOHOL 6 115 2.17e-05 0.0002274
445 IN UTERO EMBRYONIC DEVELOPMENT 9 311 2.217e-05 0.0002313
446 RESPONSE TO OXYGEN LEVELS 9 311 2.217e-05 0.0002313
447 SYNAPSE ASSEMBLY 5 69 2.235e-05 0.0002326
448 SPECIFICATION OF SYMMETRY 6 117 2.393e-05 0.0002485
449 POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION 3 12 2.431e-05 0.0002502
450 TRACHEA MORPHOGENESIS 3 12 2.431e-05 0.0002502
451 MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 3 12 2.431e-05 0.0002502
452 REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 3 12 2.431e-05 0.0002502
453 POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 7 175 2.467e-05 0.0002533
454 MESODERM DEVELOPMENT 6 118 2.511e-05 0.0002574
455 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 5 71 2.569e-05 0.0002615
456 SKIN EPIDERMIS DEVELOPMENT 5 71 2.569e-05 0.0002615
457 CELL FATE SPECIFICATION 5 71 2.569e-05 0.0002615
458 ENDOTHELIAL CELL DIFFERENTIATION 5 72 2.75e-05 0.0002794
459 REGULATION OF CELL CYCLE PHASE TRANSITION 9 321 2.842e-05 0.0002881
460 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 6 121 2.894e-05 0.0002928
461 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 6 122 3.032e-05 0.000306
462 HEMATOPOIETIC STEM CELL PROLIFERATION 3 13 3.149e-05 0.0003157
463 REGULATION OF SKELETAL MUSCLE ADAPTATION 3 13 3.149e-05 0.0003157
464 REGULATION OF CELL FATE SPECIFICATION 3 13 3.149e-05 0.0003157
465 REGULATION OF MUSCLE HYPERTROPHY 4 37 3.162e-05 0.0003164
466 REGULATION OF NEURON PROJECTION DEVELOPMENT 10 408 3.169e-05 0.0003164
467 T CELL DIFFERENTIATION 6 123 3.175e-05 0.0003164
468 RESPONSE TO STEROID HORMONE 11 497 3.191e-05 0.0003173
469 REGULATION OF MYELOID CELL DIFFERENTIATION 7 183 3.285e-05 0.0003238
470 PROTEIN COMPLEX BIOGENESIS 17 1132 3.282e-05 0.0003238
471 OSSIFICATION 8 251 3.274e-05 0.0003238
472 PROTEIN COMPLEX ASSEMBLY 17 1132 3.282e-05 0.0003238
473 NEURAL CREST CELL DIFFERENTIATION 5 75 3.353e-05 0.0003298
474 EPIDERMIS DEVELOPMENT 8 253 3.464e-05 0.00034
475 RESPONSE TO RADIATION 10 413 3.513e-05 0.0003441
476 EPITHELIAL CELL DEVELOPMENT 7 186 3.644e-05 0.0003547
477 RESPONSE TO UV 6 126 3.637e-05 0.0003547
478 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 6 126 3.637e-05 0.0003547
479 CELL CYCLE PHASE TRANSITION 8 255 3.663e-05 0.0003558
480 REGULATION OF BMP SIGNALING PATHWAY 5 77 3.809e-05 0.0003692
481 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 7 188 3.901e-05 0.0003774
482 POSITIVE REGULATION OF MEIOTIC CELL CYCLE 3 14 3.993e-05 0.0003847
483 REGULATION OF MONOCYTE DIFFERENTIATION 3 14 3.993e-05 0.0003847
484 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 6 129 4.151e-05 0.0003982
485 REGULATION OF REPRODUCTIVE PROCESS 6 129 4.151e-05 0.0003982
486 MAMMARY GLAND MORPHOGENESIS 4 40 4.326e-05 0.0004117
487 FORELIMB MORPHOGENESIS 4 40 4.326e-05 0.0004117
488 REGULATION OF MEIOTIC CELL CYCLE 4 40 4.326e-05 0.0004117
489 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 4 40 4.326e-05 0.0004117
490 SYNAPTIC SIGNALING 10 424 4.384e-05 0.0004163
491 PROTEIN STABILIZATION 6 131 4.525e-05 0.0004288
492 CELLULAR RESPONSE TO MECHANICAL STIMULUS 5 80 4.581e-05 0.0004332
493 ACTIVATION OF IMMUNE RESPONSE 10 427 4.651e-05 0.000439
494 EAR DEVELOPMENT 7 195 4.921e-05 0.0004625
495 REGULATION OF MUSCLE SYSTEM PROCESS 7 195 4.921e-05 0.0004625
496 NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS 3 15 4.974e-05 0.0004666
497 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 4 42 5.259e-05 0.0004924
498 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 6 135 5.354e-05 0.0005003
499 HAIR CYCLE 5 83 5.469e-05 0.0005089
500 MOLTING CYCLE 5 83 5.469e-05 0.0005089
501 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 9 351 5.687e-05 0.0005281
502 REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 4 43 5.777e-05 0.0005354
503 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 5 84 5.793e-05 0.0005359
504 CELLULAR RESPONSE TO RADIATION 6 137 5.812e-05 0.0005366
505 PLACENTA DEVELOPMENT 6 138 6.052e-05 0.0005577
506 ORGAN INDUCTION 3 16 6.1e-05 0.0005587
507 REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 8 274 6.079e-05 0.0005587
508 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 3 16 6.1e-05 0.0005587
509 MITOTIC CELL CYCLE CHECKPOINT 6 139 6.301e-05 0.000576
510 LABYRINTHINE LAYER DEVELOPMENT 4 44 6.331e-05 0.0005776
511 NEURON PROJECTION GUIDANCE 7 205 6.747e-05 0.0006144
512 TISSUE REMODELING 5 87 6.853e-05 0.0006228
513 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 5 88 7.238e-05 0.0006565
514 NEURON PROJECTION DEVELOPMENT 11 545 7.325e-05 0.0006631
515 CELLULAR RESPONSE TO LITHIUM ION 3 17 7.38e-05 0.0006655
516 NEGATIVE REGULATION OF STEM CELL PROLIFERATION 3 17 7.38e-05 0.0006655
517 RESPONSE TO NITROGEN COMPOUND 14 859 7.451e-05 0.0006706
518 REGULATION OF CHONDROCYTE DIFFERENTIATION 4 46 7.553e-05 0.0006785
519 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 6 144 7.667e-05 0.0006873
520 RESPONSE TO MECHANICAL STIMULUS 7 210 7.85e-05 0.0007024
521 ENDOTHELIUM DEVELOPMENT 5 90 8.058e-05 0.0007196
522 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 9 368 8.169e-05 0.0007282
523 RESPONSE TO ESTRADIOL 6 146 8.275e-05 0.0007362
524 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 7 213 8.579e-05 0.0007618
525 CELL DIVISION 10 460 8.641e-05 0.0007659
526 APOPTOTIC SIGNALING PATHWAY 8 289 8.817e-05 0.0007762
527 PERICARDIUM DEVELOPMENT 3 18 8.825e-05 0.0007762
528 INOSITOL PHOSPHATE MEDIATED SIGNALING 3 18 8.825e-05 0.0007762
529 UTERUS DEVELOPMENT 3 18 8.825e-05 0.0007762
530 TAXIS 10 464 9.28e-05 0.0008148
531 REGULATION OF DNA BINDING 5 93 9.419e-05 0.0008253
532 CELLULAR RESPONSE TO CALCIUM ION 4 49 9.697e-05 0.0008481
533 RESPONSE TO ESTROGEN 7 218 9.916e-05 0.0008657
534 REGULATION OF MUSCLE CELL DIFFERENTIATION 6 152 0.0001033 0.0009005
535 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 5 95 0.0001042 0.0009045
536 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 5 95 0.0001042 0.0009045
537 POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 4 50 0.000105 0.0009099
538 GLAND MORPHOGENESIS 5 97 0.000115 0.0009947
539 REGULATION OF HORMONE LEVELS 10 478 0.0001184 0.001022
540 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 6 156 0.0001192 0.001027
541 POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 5 98 0.0001207 0.001038
542 POSITIVE REGULATION OF REPRODUCTIVE PROCESS 4 52 0.0001225 0.00105
543 TONGUE DEVELOPMENT 3 20 0.0001224 0.00105
544 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 5 99 0.0001267 0.001083
545 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 4 53 0.000132 0.001127
546 NEURON DEVELOPMENT 12 687 0.0001337 0.00114
547 VENTRICULAR SEPTUM DEVELOPMENT 4 54 0.0001421 0.001208
548 BONE RESORPTION 3 21 0.0001423 0.001208
549 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 7 232 0.0001459 0.00123
550 REGULATION OF LEUKOCYTE DIFFERENTIATION 7 232 0.0001459 0.00123
551 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 5 102 0.0001458 0.00123
552 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 7 232 0.0001459 0.00123
553 REGULATION OF NUCLEAR DIVISION 6 163 0.0001516 0.001275
554 REGULATION OF CIRCADIAN RHYTHM 5 103 0.0001526 0.00128
555 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 5 103 0.0001526 0.00128
556 CELL SUBSTRATE ADHESION 6 164 0.0001567 0.001311
557 REGULATION OF SECRETION 12 699 0.0001571 0.001312
558 NEURON PROJECTION MORPHOGENESIS 9 402 0.0001592 0.001328
559 MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 3 22 0.0001642 0.001357
560 POSITIVE REGULATION OF MUSCLE HYPERTROPHY 3 22 0.0001642 0.001357
561 POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY 3 22 0.0001642 0.001357
562 REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 3 22 0.0001642 0.001357
563 EMBRYONIC PLACENTA MORPHOGENESIS 3 22 0.0001642 0.001357
564 ODONTOGENESIS 5 105 0.0001671 0.001378
565 CARDIAC VENTRICLE DEVELOPMENT 5 106 0.0001747 0.001439
566 REGULATION OF AXONOGENESIS 6 168 0.0001786 0.001469
567 REGULATION OF OSTEOBLAST PROLIFERATION 3 23 0.0001882 0.001544
568 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 6 171 0.0001967 0.001611
569 NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS 5 109 0.0001991 0.001625
570 RESPONSE TO HYDROGEN PEROXIDE 5 109 0.0001991 0.001625
571 POSITIVE REGULATION OF INNATE IMMUNE RESPONSE 7 246 0.0002091 0.001704
572 POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 3 24 0.0002143 0.001734
573 EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 3 24 0.0002143 0.001734
574 CHONDROCYTE DIFFERENTIATION 4 60 0.0002142 0.001734
575 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 3 24 0.0002143 0.001734
576 CELL CYCLE G1 S PHASE TRANSITION 5 111 0.0002167 0.001744
577 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 5 111 0.0002167 0.001744
578 G1 S TRANSITION OF MITOTIC CELL CYCLE 5 111 0.0002167 0.001744
579 PEPTIDYL AMINO ACID MODIFICATION 13 841 0.0002313 0.001859
580 LENS FIBER CELL DIFFERENTIATION 3 25 0.0002426 0.00194
581 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 3 25 0.0002426 0.00194
582 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 25 0.0002426 0.00194
583 POSITIVE REGULATION OF NUCLEAR DIVISION 4 62 0.0002432 0.001941
584 HOMEOSTATIC PROCESS 17 1337 0.0002501 0.001993
585 NEUROEPITHELIAL CELL DIFFERENTIATION 4 63 0.0002587 0.002058
586 FEMALE SEX DIFFERENTIATION 5 116 0.000266 0.002112
587 REGULATION OF PEPTIDE TRANSPORT 7 256 0.0002665 0.002112
588 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 3 26 0.0002733 0.002159
589 REGULATION OF CELL FATE COMMITMENT 3 26 0.0002733 0.002159
590 RESPONSE TO KETONE 6 182 0.0002753 0.002171
591 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 5 117 0.0002768 0.002179
592 COVALENT CHROMATIN MODIFICATION 8 345 0.0002955 0.002322
593 CELL JUNCTION ORGANIZATION 6 185 0.0003005 0.002358
594 REGULATION OF HORMONE SECRETION 7 262 0.0003066 0.002402
595 CELLULAR RESPONSE TO UV 4 66 0.0003095 0.00242
596 CHROMATIN MODIFICATION 10 539 0.0003113 0.002427
597 REGULATION OF DENDRITE DEVELOPMENT 5 120 0.0003112 0.002427
598 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 4 67 0.0003279 0.002547
599 REGULATION OF SISTER CHROMATID SEGREGATION 4 67 0.0003279 0.002547
600 CHEMICAL HOMEOSTASIS 13 874 0.0003352 0.002597
601 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 5 122 0.0003359 0.002597
602 CELLULAR RESPONSE TO INTERFERON GAMMA 5 122 0.0003359 0.002597
603 MYELOID CELL DIFFERENTIATION 6 189 0.0003369 0.0026
604 PLACENTA BLOOD VESSEL DEVELOPMENT 3 28 0.0003419 0.002625
605 NEGATIVE REGULATION OF DENDRITE DEVELOPMENT 3 28 0.0003419 0.002625
606 METANEPHROS MORPHOGENESIS 3 28 0.0003419 0.002625
607 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 4 68 0.0003471 0.002657
608 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 6 190 0.0003466 0.002657
609 POSITIVE REGULATION OF MITOTIC CELL CYCLE 5 123 0.0003488 0.002665
610 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 6 191 0.0003564 0.002719
611 POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 6 192 0.0003665 0.002791
612 NEGATIVE REGULATION OF OSSIFICATION 4 69 0.0003671 0.002791
613 CELLULAR RESPONSE TO HORMONE STIMULUS 10 552 0.0003758 0.002852
614 REGULATION OF MEIOTIC NUCLEAR DIVISION 3 29 0.00038 0.002875
615 EMBRYONIC HINDLIMB MORPHOGENESIS 3 29 0.00038 0.002875
616 MUSCLE ORGAN MORPHOGENESIS 4 70 0.0003879 0.002921
617 INTERFERON GAMMA MEDIATED SIGNALING PATHWAY 4 70 0.0003879 0.002921
618 CELL CYCLE CHECKPOINT 6 194 0.0003872 0.002921
619 ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 6 195 0.000398 0.002992
620 CHROMATIN ORGANIZATION 11 663 0.0004006 0.003006
621 POSITIVE REGULATION OF BINDING 5 127 0.0004042 0.003028
622 ENDODERM DEVELOPMENT 4 71 0.0004095 0.003064
623 PROTEIN LOCALIZATION 20 1805 0.0004124 0.00308
624 ESTABLISHMENT OR MAINTENANCE OF EPITHELIAL CELL APICAL BASAL POLARITY 3 30 0.0004208 0.003103
625 SMOOTH MUSCLE CELL DIFFERENTIATION 3 30 0.0004208 0.003103
626 POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 3 30 0.0004208 0.003103
627 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 3 30 0.0004208 0.003103
628 MACROMOLECULAR COMPLEX ASSEMBLY 17 1398 0.0004203 0.003103
629 ESTABLISHMENT OF ENDOTHELIAL BARRIER 3 30 0.0004208 0.003103
630 RESPONSE TO X RAY 3 30 0.0004208 0.003103
631 MUSCLE CELL DEVELOPMENT 5 128 0.000419 0.003103
632 CELL PROJECTION ORGANIZATION 13 902 0.0004525 0.003331
633 POSITIVE REGULATION OF PROTEIN BINDING 4 73 0.0004554 0.003342
634 PANCREAS DEVELOPMENT 4 73 0.0004554 0.003342
635 RESPONSE TO LIGHT STIMULUS 7 280 0.000457 0.003349
636 REGULATION OF DENDRITE MORPHOGENESIS 4 74 0.0004796 0.003509
637 ACTIVATION OF INNATE IMMUNE RESPONSE 6 204 0.0005054 0.003692
638 ADIPOSE TISSUE DEVELOPMENT 3 32 0.0005104 0.003722
639 PROTEIN CATABOLIC PROCESS 10 579 0.0005455 0.003968
640 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 6 207 0.0005458 0.003968
641 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 5 136 0.0005527 0.004012
642 DIENCEPHALON DEVELOPMENT 4 77 0.0005578 0.004042
643 EMBRYONIC EYE MORPHOGENESIS 3 33 0.0005594 0.004048
644 REGULATION OF CELL CELL ADHESION 8 380 0.0005608 0.004052
645 HINDBRAIN DEVELOPMENT 5 137 0.0005715 0.004123
646 REGULATION OF PEPTIDE SECRETION 6 209 0.0005741 0.004135
647 REGULATION OF PROTEIN DEACETYLATION 3 34 0.0006114 0.004377
648 ORGAN FORMATION 3 34 0.0006114 0.004377
649 PROTEIN DESTABILIZATION 3 34 0.0006114 0.004377
650 NEURAL TUBE PATTERNING 3 34 0.0006114 0.004377
651 REGULATION OF SYNAPTIC PLASTICITY 5 140 0.0006305 0.004507
652 REGULATION OF PROTEIN SECRETION 8 389 0.0006536 0.004665
653 REGULATION OF GASTRULATION 3 35 0.0006664 0.004734
654 RESPONSE TO MINERALOCORTICOID 3 35 0.0006664 0.004734
655 EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 3 35 0.0006664 0.004734
656 PLATELET ACTIVATION 5 142 0.0006724 0.004769
657 METANEPHROS DEVELOPMENT 4 81 0.0006756 0.004777
658 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 4 81 0.0006756 0.004777
659 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 5 143 0.0006941 0.004901
660 MODULATION OF SYNAPTIC TRANSMISSION 7 301 0.0007014 0.004945
661 JNK CASCADE 4 82 0.0007076 0.004981
662 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 6 218 0.0007159 0.005027
663 RESPONSE TO INTERFERON GAMMA 5 144 0.0007163 0.005027
664 POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 3 36 0.0007244 0.005068
665 HEAD MORPHOGENESIS 3 36 0.0007244 0.005068
666 EMBRYONIC PLACENTA DEVELOPMENT 4 83 0.0007406 0.005174
667 NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION 5 146 0.0007623 0.005318
668 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 4 84 0.0007747 0.00538
669 POSITIVE REGULATION OF NEURON DIFFERENTIATION 7 306 0.0007726 0.00538
670 CELLULAR RESPONSE TO CYTOKINE STIMULUS 10 606 0.0007747 0.00538
671 HINDLIMB MORPHOGENESIS 3 37 0.0007855 0.005419
672 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 5 147 0.0007861 0.005419
673 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 3 37 0.0007855 0.005419
674 ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY 3 37 0.0007855 0.005419
675 ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY 3 37 0.0007855 0.005419
676 CALCIUM ION TRANSPORT 6 223 0.0008057 0.005545
677 REGULATION OF CHROMOSOME SEGREGATION 4 85 0.00081 0.005567
678 CELLULAR RESPONSE TO NITROGEN COMPOUND 9 505 0.0008361 0.005738
679 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 3 38 0.0008498 0.005815
680 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 3 38 0.0008498 0.005815
681 REGULATION OF SYSTEM PROCESS 9 507 0.0008597 0.005874
682 REGULATION OF HEMOPOIESIS 7 314 0.0008984 0.006129
683 REGULATION OF CHROMATIN ORGANIZATION 5 152 0.0009136 0.006224
684 POSITIVE REGULATION OF VIRAL TRANSCRIPTION 3 39 0.0009173 0.006231
685 NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 3 39 0.0009173 0.006231
686 SYSTEM PROCESS 19 1785 0.0009591 0.006506
687 CALCIUM MEDIATED SIGNALING 4 90 0.001003 0.006795
688 PROTEIN LOCALIZATION TO NUCLEUS 5 156 0.001026 0.006941
689 CELLULAR RESPONSE TO LIGHT STIMULUS 4 91 0.001045 0.007061
690 POSITIVE REGULATION OF MULTI ORGANISM PROCESS 5 157 0.001056 0.007121
691 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 3 41 0.001062 0.007123
692 NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE 3 41 0.001062 0.007123
693 NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 3 41 0.001062 0.007123
694 PROSTATE GLAND DEVELOPMENT 3 41 0.001062 0.007123
695 CELL PART MORPHOGENESIS 10 633 0.001078 0.007219
696 DENDRITE MORPHOGENESIS 3 42 0.00114 0.0076
697 EPITHELIAL CELL MORPHOGENESIS 3 42 0.00114 0.0076
698 GENITALIA DEVELOPMENT 3 42 0.00114 0.0076
699 NEGATIVE REGULATION OF PROTEOLYSIS 7 329 0.001177 0.007837
700 REGENERATION 5 161 0.001181 0.007851
701 NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 3 43 0.001221 0.008095
702 CEREBRAL CORTEX CELL MIGRATION 3 43 0.001221 0.008095
703 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 4 95 0.001227 0.008121
704 CELLULAR RESPONSE TO BIOTIC STIMULUS 5 163 0.001248 0.008247
705 PRIMITIVE STREAK FORMATION 2 11 0.00127 0.008347
706 ENDOCARDIUM DEVELOPMENT 2 11 0.00127 0.008347
707 NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 2 11 0.00127 0.008347
708 OLFACTORY BULB INTERNEURON DEVELOPMENT 2 11 0.00127 0.008347
709 CHROMOSOME ORGANIZATION 13 1009 0.001274 0.008359
710 MYELOID LEUKOCYTE DIFFERENTIATION 4 96 0.001275 0.008359
711 BODY MORPHOGENESIS 3 44 0.001306 0.008535
712 NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 3 44 0.001306 0.008535
713 REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 4 97 0.001325 0.00865
714 MULTICELLULAR ORGANISM REPRODUCTION 11 768 0.001338 0.008717
715 REGULATION OF EPITHELIAL CELL MIGRATION 5 166 0.001353 0.008803
716 RESPONSE TO VITAMIN 4 98 0.001377 0.008934
717 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 4 98 0.001377 0.008934
718 ENDOTHELIAL CELL DEVELOPMENT 3 45 0.001394 0.009024
719 LUNG MORPHOGENESIS 3 45 0.001394 0.009024
720 RESPONSE TO CARBOHYDRATE 5 168 0.001426 0.009218
721 COGNITION 6 251 0.00148 0.009549
722 MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM 4 100 0.001483 0.009553
723 NEGATIVE REGULATION OF DNA BINDING 3 46 0.001486 0.009553
724 HISTONE H3 ACETYLATION 3 46 0.001486 0.009553
725 KERATINOCYTE PROLIFERATION 2 12 0.001519 0.00963
726 ANTERIOR POSTERIOR AXIS SPECIFICATION EMBRYO 2 12 0.001519 0.00963
727 CARTILAGE MORPHOGENESIS 2 12 0.001519 0.00963
728 ANATOMICAL STRUCTURE REGRESSION 2 12 0.001519 0.00963
729 ROSTROCAUDAL NEURAL TUBE PATTERNING 2 12 0.001519 0.00963
730 HEART FORMATION 2 12 0.001519 0.00963
731 TRIPARTITE REGIONAL SUBDIVISION 2 12 0.001519 0.00963
732 POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS 2 12 0.001519 0.00963
733 EMBRYONIC CAMERA TYPE EYE FORMATION 2 12 0.001519 0.00963
734 LENS FIBER CELL DEVELOPMENT 2 12 0.001519 0.00963
735 REGULATION OF EXTENT OF CELL GROWTH 4 101 0.001539 0.009741
736 REGULATION OF CELL SIZE 5 172 0.001582 0.009976
737 POSITIVE REGULATION OF DEPHOSPHORYLATION 3 47 0.001582 0.009976
738 POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 3 47 0.001582 0.009976
NumGOOverlapSizeP ValueAdj. P Value
1 FRIZZLED BINDING 17 36 9.984e-31 9.275e-28
2 WNT ACTIVATED RECEPTOR ACTIVITY 14 22 5.404e-28 2.51e-25
3 WNT PROTEIN BINDING 15 31 2.07e-27 6.409e-25
4 BETA CATENIN BINDING 18 84 3.746e-25 8.699e-23
5 G PROTEIN COUPLED RECEPTOR BINDING 17 259 8.585e-15 1.595e-12
6 ENZYME BINDING 33 1737 3.466e-12 5.366e-10
7 TRANSCRIPTION FACTOR BINDING 19 524 8.174e-12 1.002e-09
8 RECEPTOR BINDING 30 1476 8.629e-12 1.002e-09
9 SIGNAL TRANSDUCER ACTIVITY 32 1731 1.706e-11 1.761e-09
10 PROTEIN SERINE THREONINE KINASE ACTIVITY 17 445 5.188e-11 4.819e-09
11 RECEPTOR AGONIST ACTIVITY 6 16 9.122e-11 7.704e-09
12 MOLECULAR FUNCTION REGULATOR 26 1353 1.018e-09 7.882e-08
13 PROTEIN KINASE ACTIVITY 18 640 1.847e-09 1.32e-07
14 REGULATORY REGION NUCLEIC ACID BINDING 20 818 2.291e-09 1.52e-07
15 KINASE BINDING 17 606 5.728e-09 3.548e-07
16 RECEPTOR ACTIVATOR ACTIVITY 6 32 9.691e-09 5.627e-07
17 CORE PROMOTER PROXIMAL REGION DNA BINDING 13 371 3.237e-08 1.769e-06
18 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 8 104 4.351e-08 2.246e-06
19 PROTEIN DOMAIN SPECIFIC BINDING 16 624 5.884e-08 2.877e-06
20 SMAD BINDING 7 72 6.199e-08 2.879e-06
21 RECEPTOR REGULATOR ACTIVITY 6 45 8.275e-08 3.661e-06
22 KINASE ACTIVITY 18 842 1.242e-07 5.244e-06
23 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 15 588 1.705e-07 6.888e-06
24 GAMMA CATENIN BINDING 4 12 2.603e-07 1.008e-05
25 PDZ DOMAIN BINDING 7 90 2.926e-07 1.087e-05
26 ARMADILLO REPEAT DOMAIN BINDING 4 13 3.746e-07 1.339e-05
27 RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 5 36 8.517e-07 2.931e-05
28 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 18 992 1.356e-06 4.499e-05
29 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 14 629 2.293e-06 7.344e-05
30 PROTEIN DIMERIZATION ACTIVITY 19 1149 2.612e-06 8.09e-05
31 PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY 4 21 3.043e-06 9.119e-05
32 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 10 315 3.353e-06 9.734e-05
33 R SMAD BINDING 4 23 4.468e-06 0.0001258
34 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 10 328 4.796e-06 0.000131
35 UBIQUITIN LIKE PROTEIN LIGASE BINDING 9 264 6.001e-06 0.0001593
36 ACTIVATING TRANSCRIPTION FACTOR BINDING 5 57 8.721e-06 0.000225
37 CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY 4 28 1.014e-05 0.0002546
38 TRANSCRIPTION COACTIVATOR ACTIVITY 9 296 1.5e-05 0.0003668
39 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 8 226 1.543e-05 0.0003676
40 ENZYME REGULATOR ACTIVITY 16 959 1.617e-05 0.0003756
41 I SMAD BINDING 3 11 1.83e-05 0.0004128
42 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 18 1199 1.866e-05 0.0004128
43 DOUBLE STRANDED DNA BINDING 14 764 2.086e-05 0.0004506
44 CALMODULIN BINDING 7 179 2.852e-05 0.0006021
45 RHO GTPASE BINDING 5 78 4.054e-05 0.0008187
46 MAP KINASE ACTIVITY 3 14 3.993e-05 0.0008187
47 SEQUENCE SPECIFIC DNA BINDING 16 1037 4.18e-05 0.0008263
48 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING 3 15 4.974e-05 0.0009626
49 CHROMATIN BINDING 10 435 5.434e-05 0.00103
50 PHOSPHATASE REGULATOR ACTIVITY 5 87 6.853e-05 0.001273
51 HORMONE RECEPTOR BINDING 6 168 0.0001786 0.003254
52 RECEPTOR SIGNALING PROTEIN ACTIVITY 6 172 0.000203 0.003626
53 PROTEIN HOMODIMERIZATION ACTIVITY 12 722 0.0002118 0.003713
54 BHLH TRANSCRIPTION FACTOR BINDING 3 28 0.0003419 0.005775
55 CADHERIN BINDING 3 28 0.0003419 0.005775
56 NF KAPPAB BINDING 3 30 0.0004208 0.00698
57 PHOSPHOLIPASE C ACTIVITY 3 31 0.0004642 0.007565
58 PROTEIN HETERODIMERIZATION ACTIVITY 9 468 0.0004861 0.007787
NumGOOverlapSizeP ValueAdj. P Value
1 WNT SIGNALOSOME 10 11 5.45e-23 3.183e-20
2 BETA CATENIN DESTRUCTION COMPLEX 7 14 1.82e-13 5.314e-11
3 ENDOCYTIC VESICLE MEMBRANE 12 152 1.109e-11 2.16e-09
4 ENDOCYTIC VESICLE 12 256 4.583e-09 6.692e-07
5 EXTRACELLULAR MATRIX 14 426 2.05e-08 1.995e-06
6 PROTEINACEOUS EXTRACELLULAR MATRIX 13 356 1.992e-08 1.995e-06
7 TRANSCRIPTION FACTOR COMPLEX 12 298 2.49e-08 2.077e-06
8 PROTEIN PHOSPHATASE TYPE 2A COMPLEX 5 20 3.727e-08 2.721e-06
9 PHOSPHATASE COMPLEX 6 48 1.232e-07 7.995e-06
10 SYNAPSE 17 754 1.376e-07 8.036e-06
11 LATERAL PLASMA MEMBRANE 6 50 1.583e-07 8.404e-06
12 CHROMOSOME 18 880 2.388e-07 1.162e-05
13 VESICLE MEMBRANE 13 512 1.287e-06 5.783e-05
14 TRANSCRIPTIONAL REPRESSOR COMPLEX 6 74 1.679e-06 6.127e-05
15 CHROMATIN 12 441 1.666e-06 6.127e-05
16 NUCLEAR CHROMATIN 10 291 1.652e-06 6.127e-05
17 CATALYTIC COMPLEX 18 1038 2.577e-06 8.851e-05
18 CELL SURFACE 15 757 4.011e-06 0.0001301
19 CYTOPLASMIC VESICLE PART 13 601 7.407e-06 0.0002277
20 INTRACELLULAR VESICLE 19 1259 9.763e-06 0.0002851
21 NUCLEAR TRANSCRIPTION FACTOR COMPLEX 6 127 3.802e-05 0.001057
22 SYNAPSE PART 12 610 4.324e-05 0.001148
23 CYTOSKELETAL PART 19 1436 6.013e-05 0.001527
24 PROTEIN KINASE COMPLEX 5 90 8.058e-05 0.001961
25 GOLGI LUMEN 5 94 9.91e-05 0.002315
26 MICROTUBULE CYTOSKELETON 15 1068 0.0002104 0.004673
27 CHROMOSOME CENTROMERIC REGION 6 174 0.0002161 0.004673
28 NUCLEAR CHROMOSOME 10 523 0.000245 0.00511
29 EXCITATORY SYNAPSE 6 197 0.0004201 0.008461
30 CYTOSKELETON 21 1967 0.000474 0.00865
31 NUCLEAR MEMBRANE 7 280 0.000457 0.00865
32 CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX 3 31 0.0004642 0.00865

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04310_Wnt_signaling_pathway 98 151 8.08e-227 1.454e-224
2 hsa04916_Melanogenesis 40 101 7.258e-69 6.532e-67
3 hsa04390_Hippo_signaling_pathway 41 154 3.325e-62 1.995e-60
4 hsa04340_Hedgehog_signaling_pathway 17 56 1.054e-26 4.743e-25
5 hsa04720_Long.term_potentiation 15 70 4.266e-21 1.536e-19
6 hsa04114_Oocyte_meiosis 15 114 1.038e-17 3.113e-16
7 hsa04520_Adherens_junction 13 73 2.79e-17 7.173e-16
8 hsa04912_GnRH_signaling_pathway 14 101 6.352e-17 1.429e-15
9 hsa04971_Gastric_acid_secretion 11 74 7.114e-14 1.423e-12
10 hsa04662_B_cell_receptor_signaling_pathway 11 75 8.304e-14 1.495e-12
11 hsa04010_MAPK_signaling_pathway 16 268 2.451e-13 4.012e-12
12 hsa04012_ErbB_signaling_pathway 11 87 4.525e-13 6.787e-12
13 hsa04370_VEGF_signaling_pathway 10 76 3.644e-12 4.709e-11
14 hsa04020_Calcium_signaling_pathway 13 177 3.662e-12 4.709e-11
15 hsa04510_Focal_adhesion 13 200 1.725e-11 2.07e-10
16 hsa04722_Neurotrophin_signaling_pathway 10 127 6.505e-10 7.318e-09
17 hsa04360_Axon_guidance 10 130 8.188e-10 8.669e-09
18 hsa04650_Natural_killer_cell_mediated_cytotoxicity 10 136 1.275e-09 1.275e-08
19 hsa04660_T_cell_receptor_signaling_pathway 9 108 2.937e-09 2.782e-08
20 hsa04350_TGF.beta_signaling_pathway 8 85 8.772e-09 7.895e-08
21 hsa04110_Cell_cycle 9 128 1.321e-08 1.132e-07
22 hsa04062_Chemokine_signaling_pathway 10 189 3.051e-08 2.496e-07
23 hsa04730_Long.term_depression 7 70 5.085e-08 3.979e-07
24 hsa04270_Vascular_smooth_muscle_contraction 8 116 1.023e-07 7.671e-07
25 hsa04330_Notch_signaling_pathway 6 47 1.082e-07 7.793e-07
26 hsa04151_PI3K_AKT_signaling_pathway 12 351 1.486e-07 1.029e-06
27 hsa04380_Osteoclast_differentiation 8 128 2.194e-07 1.462e-06
28 hsa04970_Salivary_secretion 7 89 2.709e-07 1.742e-06
29 hsa04540_Gap_junction 7 90 2.926e-07 1.816e-06
30 hsa04664_Fc_epsilon_RI_signaling_pathway 6 79 2.47e-06 1.482e-05
31 hsa04972_Pancreatic_secretion 6 101 1.033e-05 5.995e-05
32 hsa04670_Leukocyte_transendothelial_migration 6 117 2.393e-05 0.0001346
33 hsa04070_Phosphatidylinositol_signaling_system 5 78 4.054e-05 0.0002211
34 hsa04530_Tight_junction 6 133 4.926e-05 0.0002608
35 hsa03015_mRNA_surveillance_pathway 5 83 5.469e-05 0.0002813
36 hsa04630_Jak.STAT_signaling_pathway 6 155 0.0001151 0.0005753
37 hsa04620_Toll.like_receptor_signaling_pathway 5 102 0.0001458 0.0007093
38 hsa04014_Ras_signaling_pathway 7 236 0.0001621 0.0007678
39 hsa04910_Insulin_signaling_pathway 5 138 0.0005907 0.002726
40 hsa04914_Progesterone.mediated_oocyte_maturation 4 87 0.0008838 0.003977
41 hsa04210_Apoptosis 4 89 0.0009623 0.004225
42 hsa04666_Fc_gamma_R.mediated_phagocytosis 4 95 0.001227 0.005258
43 hsa00562_Inositol_phosphate_metabolism 3 57 0.002756 0.01154
44 hsa04621_NOD.like_receptor_signaling_pathway 3 59 0.00304 0.01244
45 hsa04810_Regulation_of_actin_cytoskeleton 5 214 0.004064 0.01626
46 hsa04115_p53_signaling_pathway 3 69 0.00473 0.01851
47 hsa04622_RIG.I.like_receptor_signaling_pathway 3 71 0.005124 0.01962
48 hsa04710_Circadian_rhythm_._mammal 2 23 0.005623 0.02109
49 hsa04740_Olfactory_transduction 6 388 0.01211 0.04448
50 hsa04960_Aldosterone.regulated_sodium_reabsorption 2 42 0.01802 0.06486
51 hsa04962_Vasopressin.regulated_water_reabsorption 2 44 0.01967 0.06943
52 hsa04742_Taste_transduction 2 52 0.02689 0.09307
53 hsa04920_Adipocytokine_signaling_pathway 2 68 0.04393 0.1492
54 hsa04976_Bile_secretion 2 71 0.04747 0.1582
55 hsa04120_Ubiquitin_mediated_proteolysis 2 139 0.1486 0.4863
56 hsa04141_Protein_processing_in_endoplasmic_reticulum 2 168 0.1991 0.6288

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

MIR143HG

hsa-miR-141-5p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-1976;hsa-miR-205-5p;hsa-miR-339-5p;hsa-miR-361-3p;hsa-miR-429;hsa-miR-590-3p 10 DAAM2 Sponge network -6.51 0 -4.261 1.0E-5 0.654
2

EMX2OS

hsa-let-7a-3p;hsa-let-7f-2-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-944 12 AXIN2 Sponge network -6.205 0.00015 -3.824 0.00033 0.595
3

MAGI2-AS3

hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-330-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-592;hsa-miR-629-3p 14 PRICKLE2 Sponge network -4.563 0 -3.451 0 0.558
4

RP11-166D19.1

hsa-let-7f-1-3p;hsa-miR-146a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-484;hsa-miR-590-3p;hsa-miR-592;hsa-miR-629-3p 14 PRICKLE2 Sponge network -4.209 2.0E-5 -3.451 0 0.545
5

MEG3

hsa-let-7b-3p;hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-629-3p 11 PRICKLE2 Sponge network -3.613 0.00075 -3.451 0 0.532
6

MAGI2-AS3

hsa-let-7a-3p;hsa-let-7f-2-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-3614-5p;hsa-miR-590-3p 11 AXIN2 Sponge network -4.563 0 -3.824 0.00033 0.525
7

HAND2-AS1

hsa-let-7a-3p;hsa-let-7f-2-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-944 12 AXIN2 Sponge network -7.871 0 -3.824 0.00033 0.523
8

MEG3

hsa-let-7b-3p;hsa-let-7f-2-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-3614-5p;hsa-miR-944 11 AXIN2 Sponge network -3.613 0.00075 -3.824 0.00033 0.496
9

RASSF8-AS1

hsa-let-7a-3p;hsa-let-7b-3p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-224-3p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-590-3p 14 LRP6 Sponge network -2.562 0.00163 -1.511 0.00142 0.47
10

MIR143HG

hsa-let-7f-1-3p;hsa-miR-146a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-484;hsa-miR-590-3p;hsa-miR-629-3p 16 PRICKLE2 Sponge network -6.51 0 -3.451 0 0.467
11

RP11-166D19.1

hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-452-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p 15 FZD4 Sponge network -4.209 2.0E-5 -2.839 4.0E-5 0.456
12

RASSF8-AS1

hsa-let-7a-3p;hsa-let-7b-3p;hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-590-3p;hsa-miR-944 10 AXIN2 Sponge network -2.562 0.00163 -3.824 0.00033 0.431
13

MIR143HG

hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-25-3p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-32-5p;hsa-miR-361-3p;hsa-miR-363-3p;hsa-miR-429;hsa-miR-616-5p;hsa-miR-625-5p;hsa-miR-92a-3p;hsa-miR-92b-3p 15 CAMK2A Sponge network -6.51 0 -4.611 0.0001 0.402
14

RASSF8-AS1

hsa-let-7b-3p;hsa-miR-146a-5p;hsa-miR-150-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-21-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-590-3p;hsa-miR-629-3p 11 PRICKLE2 Sponge network -2.562 0.00163 -3.451 0 0.399
15

DNM3OS

hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-484;hsa-miR-590-3p;hsa-miR-629-3p 13 PRICKLE2 Sponge network -3.933 0.00059 -3.451 0 0.399
16

RP11-389C8.2

hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200c-3p;hsa-miR-3065-5p;hsa-miR-429;hsa-miR-93-5p 14 PRKACB Sponge network -3.089 2.0E-5 -1.469 0.00691 0.394
17 AC005682.5 hsa-miR-106a-5p;hsa-miR-10a-3p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-182-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-3065-3p;hsa-miR-3065-5p 11 CCND2 Sponge network -2.193 0.07184 -2.811 0.0014 0.394
18

NR2F2-AS1

hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-224-3p;hsa-miR-590-3p 11 LRP6 Sponge network -3.785 0.00281 -1.511 0.00142 0.392
19

NR2F1-AS1

hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-221-3p;hsa-miR-224-3p;hsa-miR-29b-3p;hsa-miR-590-3p 10 LRP6 Sponge network -2.961 0.00154 -1.511 0.00142 0.386
20

ACTA2-AS1

hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-224-3p;hsa-miR-29b-3p;hsa-miR-590-3p 12 LRP6 Sponge network -6.142 0.00223 -1.511 0.00142 0.384
21

MAGI2-AS3

hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-24-3p;hsa-miR-26b-3p;hsa-miR-30b-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-3607-3p;hsa-miR-590-3p 12 NFATC2 Sponge network -4.563 0 -0.286 0.824 0.384
22 RP11-244O19.1 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-93-5p 12 CCND2 Sponge network -1.318 0.0924 -2.811 0.0014 0.383
23

MAGI2-AS3

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p 15 FZD4 Sponge network -4.563 0 -2.839 4.0E-5 0.382
24

ACTA2-AS1

hsa-let-7a-3p;hsa-let-7f-2-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-944 12 AXIN2 Sponge network -6.142 0.00223 -3.824 0.00033 0.379
25 PWAR6 hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-224-3p;hsa-miR-330-3p 10 LRP6 Sponge network -3.15 0.0082 -1.511 0.00142 0.377
26 DIO3OS hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-324-3p;hsa-miR-378a-3p 13 CCND2 Sponge network -4.295 0.00689 -2.811 0.0014 0.374
27

RP11-284N8.3

hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-3065-5p;hsa-miR-93-5p;hsa-miR-96-5p 10 PRKACB Sponge network -0.845 0.52848 -1.469 0.00691 0.371
28

MEG3

hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-25-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-629-3p 13 FZD4 Sponge network -3.613 0.00075 -2.839 4.0E-5 0.369
29

TPTEP1

hsa-let-7a-3p;hsa-let-7f-2-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-3614-5p;hsa-miR-590-3p 10 AXIN2 Sponge network -4.398 5.0E-5 -3.824 0.00033 0.368
30

ADAMTS9-AS1

hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-330-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-1-3p 11 PRICKLE2 Sponge network -8.573 0.00012 -3.451 0 0.366
31

HAND2-AS1

hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-629-3p 14 PRICKLE2 Sponge network -7.871 0 -3.451 0 0.365
32

MAGI2-AS3

hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200c-3p;hsa-miR-3065-5p;hsa-miR-429;hsa-miR-93-5p 15 PRKACB Sponge network -4.563 0 -1.469 0.00691 0.359
33

MIR143HG

hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-2110;hsa-miR-30c-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-330-5p;hsa-miR-616-5p;hsa-miR-92a-3p 12 WNT5A Sponge network -6.51 0 -0.335 0.71496 0.356
34

MIR143HG

hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p 13 FZD4 Sponge network -6.51 0 -2.839 4.0E-5 0.346
35

ACTA2-AS1

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-708-5p 13 FZD4 Sponge network -6.142 0.00223 -2.839 4.0E-5 0.343
36

DNM3OS

hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p 13 FZD4 Sponge network -3.933 0.00059 -2.839 4.0E-5 0.341
37 RP11-13K12.1 hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-29b-3p 10 LRP6 Sponge network -5.093 0.01151 -1.511 0.00142 0.34
38

RP11-166D19.1

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-224-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-96-5p 18 CCND2 Sponge network -4.209 2.0E-5 -2.811 0.0014 0.339
39 ZNF667-AS1 hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-224-3p;hsa-miR-29b-3p 10 LRP6 Sponge network -4.019 0.00137 -1.511 0.00142 0.339
40 RP11-439M11.1 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-20b-5p;hsa-miR-324-3p 10 CCND2 Sponge network -2.662 0.21003 -2.811 0.0014 0.337
41

DNM3OS

hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200c-3p;hsa-miR-3065-5p;hsa-miR-429;hsa-miR-93-5p;hsa-miR-96-5p 15 PRKACB Sponge network -3.933 0.00059 -1.469 0.00691 0.336
42

EMX2OS

hsa-let-7f-1-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-221-5p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-629-3p 13 PRICKLE2 Sponge network -6.205 0.00015 -3.451 0 0.335
43

MAGI2-AS3

hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-224-3p;hsa-miR-590-3p 11 LRP6 Sponge network -4.563 0 -1.511 0.00142 0.331
44 HOXA11-AS hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200c-3p 11 PRKACB Sponge network -3.349 0.00194 -1.469 0.00691 0.326
45

AC003090.1

hsa-let-7f-1-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-330-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-629-3p;hsa-miR-7-1-3p 10 PRICKLE2 Sponge network -7.817 0.00161 -3.451 0 0.323
46

MIR497HG

hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-221-5p;hsa-miR-330-5p;hsa-miR-33a-3p;hsa-miR-629-3p;hsa-miR-7-1-3p 11 PRICKLE2 Sponge network -6.146 0.00024 -3.451 0 0.321
47

MAGI2-AS3

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-224-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-9-3p;hsa-miR-93-5p 19 CCND2 Sponge network -4.563 0 -2.811 0.0014 0.315
48

RP11-284N8.3

hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-3065-5p;hsa-miR-324-3p;hsa-miR-93-5p;hsa-miR-96-5p 10 CCND2 Sponge network -0.845 0.52848 -2.811 0.0014 0.313
49

MAGI2-AS3

hsa-miR-130a-5p;hsa-miR-141-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-24-3p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-429;hsa-miR-589-3p;hsa-miR-9-3p 10 PRKCB Sponge network -4.563 0 -1.378 0.12578 0.313
50

EMX2OS

hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-330-3p;hsa-miR-590-3p 11 LRP6 Sponge network -6.205 0.00015 -1.511 0.00142 0.313
51

RP11-389C8.2

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-629-3p 12 FZD4 Sponge network -3.089 2.0E-5 -2.839 4.0E-5 0.311
52

MAGI2-AS3

hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-2110;hsa-miR-30c-5p;hsa-miR-30d-3p;hsa-miR-30e-5p;hsa-miR-330-5p;hsa-miR-616-5p;hsa-miR-92a-3p 11 WNT5A Sponge network -4.563 0 -0.335 0.71496 0.31
53

NR2F2-AS1

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-16-5p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-452-5p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-708-5p 11 FZD4 Sponge network -3.785 0.00281 -2.839 4.0E-5 0.309
54

MAGI2-AS3

hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-25-3p;hsa-miR-30e-5p;hsa-miR-32-5p;hsa-miR-363-3p;hsa-miR-429;hsa-miR-616-5p;hsa-miR-92a-3p;hsa-miR-92b-3p 12 CAMK2A Sponge network -4.563 0 -4.611 0.0001 0.305
55

LINC00865

hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-429 10 PRKACB Sponge network -1.585 0.19508 -1.469 0.00691 0.302
56 GAS6-AS2 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-3065-5p;hsa-miR-324-3p;hsa-miR-429 14 CCND2 Sponge network -1.941 0.0681 -2.811 0.0014 0.301
57

HAND2-AS1

hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-2355-5p;hsa-miR-24-3p;hsa-miR-26b-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-3607-3p;hsa-miR-590-3p 12 NFATC2 Sponge network -7.871 0 -0.286 0.824 0.297
58

NR2F1-AS1

hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-330-5p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-629-3p 10 PRICKLE2 Sponge network -2.961 0.00154 -3.451 0 0.295
59

RP11-389C8.2

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-224-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-93-5p 17 CCND2 Sponge network -3.089 2.0E-5 -2.811 0.0014 0.293
60 RP11-554A11.4 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-20b-5p;hsa-miR-324-3p;hsa-miR-33a-3p 10 CCND2 Sponge network -5.361 2.0E-5 -2.811 0.0014 0.29
61

TPTEP1

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-27a-3p;hsa-miR-590-3p;hsa-miR-629-3p 10 FZD4 Sponge network -4.398 5.0E-5 -2.839 4.0E-5 0.287
62

MIR143HG

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-224-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-93-5p 21 CCND2 Sponge network -6.51 0 -2.811 0.0014 0.285
63

WT1-AS

hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-330-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-629-3p 10 PRICKLE2 Sponge network -6.875 2.0E-5 -3.451 0 0.282
64

RP11-166D19.1

hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200c-3p;hsa-miR-429;hsa-miR-96-5p 13 PRKACB Sponge network -4.209 2.0E-5 -1.469 0.00691 0.282
65

AC003090.1

hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200c-3p;hsa-miR-93-5p;hsa-miR-96-5p 12 PRKACB Sponge network -7.817 0.00161 -1.469 0.00691 0.279
66 FAM66C hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-330-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-484;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-1-3p 14 PRICKLE2 Sponge network -2.927 0.00012 -3.451 0 0.279
67 TRHDE-AS1 hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-629-3p 13 PRICKLE2 Sponge network -6.205 0.01165 -3.451 0 0.279
68

HAND2-AS1

hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-330-3p;hsa-miR-590-3p 11 LRP6 Sponge network -7.871 0 -1.511 0.00142 0.274
69

MIR143HG

hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-205-5p;hsa-miR-224-3p;hsa-miR-330-3p;hsa-miR-590-3p 10 LRP6 Sponge network -6.51 0 -1.511 0.00142 0.273
70

HAND2-AS1

hsa-let-7a-3p;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200c-3p;hsa-miR-429;hsa-miR-93-5p 14 PRKACB Sponge network -7.871 0 -1.469 0.00691 0.272
71

RP11-166D19.1

hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-363-3p;hsa-miR-429;hsa-miR-616-5p;hsa-miR-92a-3p 10 CAMK2A Sponge network -4.209 2.0E-5 -4.611 0.0001 0.266
72 SOCS2-AS1 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-93-5p 12 CCND2 Sponge network -4.167 1.0E-5 -2.811 0.0014 0.258
73

MIR143HG

hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200c-3p;hsa-miR-3065-5p;hsa-miR-429;hsa-miR-93-5p 14 PRKACB Sponge network -6.51 0 -1.469 0.00691 0.253
74

ACTA2-AS1

hsa-let-7f-1-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-484;hsa-miR-590-3p 10 PRICKLE2 Sponge network -6.142 0.00223 -3.451 0 0.253
75

RP11-597D13.9

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-30d-3p;hsa-miR-429;hsa-miR-93-5p;hsa-miR-96-5p 14 CCND2 Sponge network -2.494 0.07597 -2.811 0.0014 0.252
76

DNM3OS

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-93-5p;hsa-miR-96-5p 19 CCND2 Sponge network -3.933 0.00059 -2.811 0.0014 0.25

Quest ID: 2c356a41cb019f10d9d78085bdfef293